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Abstract
Tissue engineering aims at reconstructing living tissue by using scaﬀolds
that are seeded with the patient’s cells in vitro, then transplanted in the
body where needed. We have investigated a bottom-up approach for
scaﬀold production and cells seeding, combining in a single step cells
encapsulation and deposition of the encapsulated cells in speciﬁc archi-
tectures. In this thesis two 3D deposition or bioprinting methods are
presented. Both methods manufacture scaﬀolds with small volumes of
material that could be the building blocks for more extended structures.
The ﬁrst system is based on the extrusion of alginate solutions while the
second exploits the electro hydro dynamic process to create a jet of liquid
alginate beads containing cells. The building blocks of the scaﬀold are
placed at predeﬁned position on a speciﬁc target substrate where they
crosslink without the need of further postprocessing. Particular attention
was given to the electro hydro dynamic process and to the investigation
of the parameters inﬂuencing the encapsulation of cells, the deposition
of the beads on the substrate, the compatibility of the printing process
conditions with cells and their survival after printing.
1
2
1. Introduction
A substantial part of tissue engineering consists in the repair of dam-
aged tissue and organs thanks to the combined use of scaﬀolds and cells.
Typically a scaﬀold is designed and fabricated, cells are seeded in vitro,
then the scaﬀold/cell combination products are transferred to the body
site where new tissue is generated. The procedure requires the selection
of proper materials, the design and the fabrication of a scaﬀold possi-
bly mimicking architecture and mechanical properties of the damaged
tissue extra cellular matrix (ECM), the seeding of cells taken from the
patient’s tissue and their cultivation in vitro in static or dynamic condi-
tions, ﬁnally the implantation of the scaﬀold/cells combined product in
the patient’s body site.
Body tissues, however, are complex structures inhabited by diﬀerent
types of cells, with continuous nutrition that is mainly provided by a
dense network of capillaries branching from the bodies main blood ves-
sels.
While tissue engineering has been so far successful with thin tissues where
the blood vessels of the host can provide nutrients via diﬀusion [43],
the vascularization of complex extended three dimensional tissues is still
an open issue [85] needing fast angiogenesis and vascularization of the
implanted scaﬀold/cell system after having been transplanted from the
culture vessel to the body.
3
Chapter 1 Introduction
An improvement could be oﬀered by computer aided systems able to
control the positioning of cells, placed at speciﬁc space coordinates to
mimic the complexity of the natural tissue following a bottom-up ap-
proach [30, 45], in order to build a scaﬀold piece by piece already con-
taining cells through a technique named bioprinting.
The success of this approach to rebuild functional living tissue is un-
likely to be in the near future but nevertheless the ability to place cells
at predeﬁned positions can potentially be exploited for a wide range of
applications that range from manufacturing devices for the release of
therapeutic molecules [26] or constructs to improve biological and phar-
maceutical in vitro testing [8].
In this work two diﬀerent methods for cells deposition were investigated.
In both cases an alginate solution in PBS is placed to a predeﬁned posi-
tion with a desktop robot that acts as the positioning system. Alginate,
the bio-ink, was used since it undergoes a fast sol-gel transition compat-
ible with cell survival and it’s relatively permissive to nutrient diﬀusion
and waste removal. A gelatin with gel-sol transition when heated at phys-
iologically compatible temperatures was used as bio-paper, to support the
bio-ink and act as a source of ions. The alginate solution crosslinks when
placed in contact with a gelatin hydrogel enriched in calcium ions, form-
ing a hydrogel while gelatin undergoes a gel-sol transition and is easily
removed after moderate heating of the bio-scaﬀold.
Both methods use the same positioning system, a Janome JR2300N desk-
top robot (Japan lent by Biotools srl a spin oﬀ from the University of
Trento, Italy), shown in Fig. 1.1, but with a diﬀerent setup and in par-
ticular with diﬀerent deposition systems. The ﬁrst method that is called
Injection in Gelatin (chapter 2), uses an extrusion head as the depo-
sition system and the depositions are performed by injecting the alginate
4
1.1 Background information
Figure 1.1.: The desktop robot placed under a biological hood used as
the positioning system for the bioprinter
solution into a gelatin hydrogel along the z axis at speciﬁc x,y coordi-
nates. The second method called Electro Hydro Dynamic Print-
ing (chapter 4) is based on the EHD process and contactless printing is
performed on the top of a gelatin coating.
1.1. Background information
1.1.1. Alginate
Alginate is a polyanionic polymer used in many diﬀerent applications [5],
it’s commonly employed as stabilizer and thickener in the food industry
and for the production of ethanol through the encapsulation of yeast cells.
It’s also an important polymer for health care, speciﬁcally for wound
5
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treatment and has been used for many applications given its absorbent
[10, 98], hemostatic [37, 83] and immunological properties [32, 68]. Since
the ﬁrst successful encapsulation of cells [53] in 1980 alginate has been
widely used for cell cultures [58, 84].
Commercially available alginate is mainly derived from brown algae [90],
dried, puriﬁed and processed to obtain a powder typically in salt form.
The polymer consists of two blocks, (1,4)-linked β-d-mannuroic and α-l-
guluronic [17].
Aqueous sodium alginate solutions can undergo a sol-gel transition in
the presence of multivalent cations. The cations cooperatively bind the
blocks of adjacent alginate chains, creating ionic interchain bridges which
cause the geliﬁcation of the polymer solution [80]. The sol-gel transition
can occur under mild conditions that are compatible with cell survival
[107]. This gelation mechanism can be exploited by external gelation
where alginate is delivered into a crosslinking solution or by internal
gelation where an insoluble salt inside the alginate release ions after pH
adjustments [15]. Divalent cations bind mainly to the guluronic blocks
with larger ions producing stronger gels [25] that can be destabilized by
phosphate buﬀer solutions, characterizing the sol-gel transition of algi-
nate as reversible [88]. Alginate can be also crosslinked using solutions of
polyelectrolytes as poly-l-lysine [66] , poly-l-ornithine [91] and chitosan
[39].
Alginate can easily form beads in the presence of a crosslinking solution
given its fast sol-gel transition. Large beads are made by dripping the
alginate in a crosslinking solution with a syringe or pipette [31, 3] while
microbeads can be prepared by atomization and emulsiﬁcation [35, 1].
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1.1.2. Electro hydro dynamic process
The history of this process starts in 1882 when Lord Rayleight estimated
theoretically the amount of charge a drop of liquid could carry, hypoth-
esizing the disruption of the droplet in small jets of liquids after this
limit. Later in 1964 Sir Taylor modeled the shape of the cone formed by
a droplet under the eﬀect of an electric ﬁeld creating the base for this
technique.
The technique consists in spraying a polymer solution pumped through a
needle connected to a high voltage generator. It’s also called electrospray
or, when is set up for the creation of ﬁbers, electrospinning [4].
The solution that forms at the tip of the needle reacts to the presence
of the charge by accumulating charges of opposite sign on its surface,
the Coulombian repulsive forces produce tangential stresses, deforming
the meniscus into a conical shape known as the Taylor cone [95]. If
the voltage is high enough the electrostatic repulsion on the surface can
overcome the surface tension at the apex of the liquid cone leading to its
disintegration (Rayleigh limit) and creating a jet of drops[71].
The key parameters of this process are the chemical composition and
physical properties of the solution, its ﬂow rate, the magnitude of the
potential diﬀerence and the diameter of the needle [99, 70]. These param-
eters inﬂuence the EHD mode [69] and, as a consequence, the geometrical
features of the drop. For example at low voltages there is no or partial
jetting determining an EHD mode called dripping, at higher voltages is
possible to obtain the stable jetting mode or the ramiﬁed-jetting mode
if the voltage is particularly high [21, 40].
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1.1.3. Gelatin
1.1.4. Commercially available bioprinters
The majority of bioprinters are custom built but lately some systems have
become commercially available. Most of these printers are constituted of
a three axes positioning system, detailed information on the deposition
process used are not always available.
Figure 1.2.: Commercially available bioprinters. From left to right:
Bioassembly tool (nScript, USA), 3D-Bioplotter (Envisiontec, Ger-
many), Bioscaﬀolder (SysENG, Germany). On the bottom the samples
obtained by those printers.
The BioAssembly Tool has a positive displacement pump [54] called
SmartPump™, the 3D-Bioplotter uses a pneumatic pump [55, 62]while
the Bioscaﬀolder seems to use a similar system. All three printers follow
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a similar principle: Thanks to a pump an extrusion through an oriﬁce
is obtained which is placed very close to the substrate. By moving the
oriﬁce or the sample, and balancing its speed to the ﬂux of solution ex-
truded, the extrusion is evenly placed on the substrate. 3D structures
are obtained by the deposition of more layers of material.
The technical data of the aforementioned printers is available in the Ap-
pendix.
Figure 1.3.: Demonstration of our print at the “notte dei ricercatori”
(researchers night), extruding a ﬂuorescein loaded gel. A 3 dimensional
grid was manufactured with 20 layers
As a comparison Fig. 1.3 shows our printer with a set up similar to
the commercially available ones, extruding a ﬂuorescein loaded gel on
a generic substrate.
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2. Scaﬀold fabrication through
injection in gelatin
2.1. Introduction
Injection in gelatin was the ﬁrst deposition method tested and it was
initially developed for aiming at possible applications in neural regenera-
tion. The neural tissue is primary constituted by neurons and glial cells.
Neurons are elongated cells (up to 1 m in humans) that electrochemically
transfer signals between diﬀerent parts of the body. The thin elongated
section of the neurons is called axon. Each axon is insulated from the out-
side environment by a sheet of myelin produced by glial cells. If the axon
is cut, the parts of the body that were connected to it cannot commu-
nicate anymore leading to drastic consequences, for example movement
impairment. In the peripheral neural system the principal glial cells are
called Schwann cells [19] and are responsible for the neural regenerative
capabilities. In fact, if a lesion is not too extended, Schwann cells can
rearrange in bands that connect the two stumps of the axons, creating
the right chemotactic environment for axon regrowth. This environment
is diﬃcult to recreate artiﬁcially since it involves very precise gradients
of diﬀerent biological molecules whose role is still not clearly deﬁned. In
the central neural system Schwann cells are absent, and the glia con-
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sists mainly of astrocytes and oligodentrocytes. In case of a lesion in the
neural tissue they create an environment that opposes regeneration, the
so called glial scar [18]. A possible strategy to help neural regeneration
is to create a scaﬀold with a cylindrical hollow structure made with a
hydrogel containing Schwann cells. So that Schwann cells can still have
chemical contact with the outside environment to create the right chemo-
tactic environment for axon regrow possibly counteracting the eﬀect of
the environment created by the glial scar [65] and physically constraining
axon regrowth[33]. There is a rising interest in using olfactory ensheating
glial cells (OEG) for this speciﬁc application [28]. OEG are cells present
in the olfactory section of the neural system (nose) and have promising
peculiar characteristics for the regeneration of the central neural system.
In fact they are the only cells belonging to the glia of the central sys-
tem known to favor axon regrown in the presence of the glial scar. It’s
not clear which of the two paths (using Schwann cells or OEG) will be
the most successful but in both cases the direct use of these cells, for
example through injection, has led to poor results given the strong in-
ﬂammatory response in the lesion site. In both cases a scaﬀold made by
an hydrogel that can separate the loaded cells from the immune system
of the patient without blocking the chemical communication with the
environment shows potential for the regenerative process. In this section
a method for printing this kind of scaﬀolds will be presented, by inject-
ing an alginate solution into a gelatin hydrogel obtaining an elongated
hollow structure.
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2.2. Materials
Alginic acid sodium salt from brown algae (alginate), calcium chloride
dihydrate and gelatin from porcine skin were purchased from Sigma-
Aldrich (USA). Phosphate buﬀer saline without calcium and magnesium
(PBS), Dulbecco’s modiﬁed eagle medium (DMEM) were purchased from
Invitrogen (USA). The positioning system of the printer is a Janome
JR2300N desktop robot (Japan), the deposition system is a Viscotec
eco-PEN300 (see sec.A.1.1) connected to a gauge 33 stainless steel needle
(O.D. 0.210 mm, I.D. 0.108mm) (Germany) lent by BIOtools srl (Italy)
2.2.1. Description of printer
The printing system is composed by a 3 motorized stages (desktop robot)
and a deposition head Fig. 2.1 (right). This last one is constituted by a
rotating sealed displacement unit, fed with a liquid or semi liquid solution
by means of a syringe. The solution is sucked from the deposition head
and forced out by a motorized rotating screw through a needle connected
to the bottom part.
The electronic controller is connected to the desktop robot, it can manage
the eco-PEN independently or by on/oﬀ impulses sent by the robot. The
electronic controller has three operation modes:
1. Time mode: a ﬂow rate and a time are set, the controller will start
the deposition for the set amount of time at the set ﬂow rate
2. Volume mode: a ﬂow rate and a volume are set, the controller will
start the deposition with the set ﬂow rate for the time necessary to
obtain a deposition of the set volume.
3. Impulse mode: the on/oﬀ signals are received through a I/O port
13
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Figure 2.1.: The deposition system of the printer, eco-PEN extrusion
head (right) and controller (left)
connected to the robot, a ﬂow rate must be set.
All three modes have an option to set the amount of liquid to suck back
at the end of the deposition to avoid post dripping.
In this experiment mode 3 was used, the start and the end of the depo-
sition were controlled by the desktop robot. This way it is possible to
couple the deposition and the positioning system to start and stop the
deposition at speciﬁc coordinates.
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2.3. Methods
2.3.1. Preparation of alginate solution and gelatin
hydrogel
Alginate powder was dissolved in PBS for 8 hours at room temperature
under mild stirring to obtain a 2 % alginate solution (2g/100ml). Two
drops of Trypan Blue 0,4% (Invitrogen) per milliliter of alginate were
added as contrast agent. Gelatin powder was added into three diﬀerent
solutions and dissolved under mild stirring condition at 40°C for 3 hours
to obtain a 10% gelatin solution. The three diﬀerent solutions used were
PBS, DMEM and a 400 mM calcium chloride obtained by dissolving the
salt in distilled water. The solutions obtained were poured inside a 48
well plate to ﬁll it completely and left at room temperature for at least
three hours for the sol-gel transition to complete.
2.3.2. Printing
The printer was calibrated for the gelatin coating, in particular z was set
at zero where the tip of the needle was at the the bottom of the Petri
dish and the z coordinate of the point where the tip of the needle was on
the top surface of the gelatin hydrogel was recorded.
For the actual printing process the needle was ﬁrst moved on top of the
gelatin and then it was moved to z=o, perforating the coating (Fig. 2.2
A). The positioning system was set to send the start signal for deposition
and, at the same time, to start moving along negative z (towards the top
of the gelatin hydrogel). The end of the deposition was set at the top
of the gelatin Fig. 2.2 B. This created an alginate column entrapped in a
gelatin hydrogel and was used as the base building block of other samples
15
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Figure 2.2.: Scheme of the printing process by injection in gelatin. First
the gelatin coating is perforated then is ﬁlled with alginate. Subsequent
depositions allow the formation of more complex structures.
obtained by repeating this deposition at diﬀerent positions. More pre-
cisely the needle was moved outside the gelatin, the x (or y) coordinate
was changed and the deposition procedure was performed again (Fig. 2.2
C) to obtain a series of vertical deposition that together formed the ﬁnal
structure.
The controller was set for a ﬂow rate of 50 µl/min and the z speed of
the positioning system at 5 mm/s.
2.3.3. Post processing
The gelatin was removed from the well plate with a pair of tweezers
and diﬀerent post processing steps were performed based on the solution
where gelatin was initially dissolved. With gelatin dissolved in PBS a
piece containing the alginate depositions was cut and placed in a calcium
chloride bath for 10 minutes to crosslink the alginate. In the other two
cases the calcium chloride bath was not needed since DMEM and the
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calcium chloride solution already contain calcium ions and the alginate
crosslinks after being extruded from the needle during the injection in
gelatin.
All samples were place in warm PBS for 30 minutes to remove the gelatin.
2.4. Results
2.4.1. Base building block, the alginate column
The vertical alginate deposition shown in Fig. 2.3 is about 100 µm in
diameter, for this reason all the structures printed using this base building
block were produced by a sequence of depositions at a distance of 100
µm.
2.4.2. More extended structures
By repeating the base building block along a line it was possible to obtain
a wall like structure, constituted by tight vertical columns.
From Fig. 2.4 it’s possible to observe that after 30 depositions there is
a layer of alginate (stained in blue) on top of the gelatin. This layer is
partially formed when the needle exits from the gelatin because the ﬂux
of alginate doesn’t stop immediately at the end of the injection.
By further increasing the number of depositions it was possible to obtain
more complex structures such as an hollow parallelepiped and a more
complex parallelepiped with 4 subdivisions. From Fig. 2.5 it’s possible
to observe the points of perforation before the injection into gelatin (top
left) and that the section constituting the deposition is characterized by
a uniform thickness (right part of ﬁgures).
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Figure 2.3.: Pictures of a single vertical injection of alginate in gelatin
(hydrogel formed starting from a water solution), on the right picture
taken with the optical microscope. Bar is 100 µm
2.4.3. Post Processing
After the warm bath in PBS to remove the gelatin only the alginate
hydrogel is left.
As seen from Fig. 2.6 the sample partially keeps it shape after the removal
of gelatin and it maintains enough mechanical properties to be lifted from
the warm bath.
2.5. Discussion
It was not possible to inject the alginate into the gelatin dissolved in the
calcium chloride solution in a clean manner, the sol-gel transition was too
18
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Figure 2.4.: 30 vertical injection in gelatin forming a continuous 3mm
section in x-z. (hydrogel formed starting from a PBS solution)
fast and a block of alginate hydrogel solution formed and stuck at the
tip of the needle after the initial depositions. As already said with this
printing system the gelatin hydrogel was perforated by the metal needle
and the hydrogel stuck at the tip ruined the sample after some deposi-
tions. The same happened for other concentrations of solution until the
calcium chloride solution was substituted with DMEM (see salt formu-
lation on page 121). Given the presence of divalent cations in DMEM
(much less than in the calcium chloride solutions tested) the process was
slightly inclined to clog and a pause was needed after some depositions
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to clean the needle. Without considering the need for crosslinking in
postprocessing, there were no other substantial diﬀerences compared to
gelatin dissolved in water.
The pictures taken from the camera didn’t show the thickness of the
deposition correctly due to the blue stain diﬀusing out from the alginate,
giving the idea of a thicker structure than it actually was. The pictures
taken with the microscope gave a better idea of the real dimensions, in
that case the stainer was not used and the sample was obtained after
dissolving the gelatin containing a single injection of alginate. It’s worth
pointing out that the needle used for the deposition was a gauge 33 with
a O.D. 0.210 mm, that is much bigger than the diameter of the alginate
column (Fig. 2.3). We think that this is due to the fact that while the
needle is removed from the gelatin, the hydrogel tries to regain its original
shape squeezing the alginate that is not completely gelly yet, coming out
from the top of the gelatin and contributing to the formation of the
alginate coating on top of the gelatin.
The deposition started inside the gelatin then the needle was moved to-
wards negative z (up) and the deposition was stopped when it reached
the top of the gelatin template. The ﬂux of solution didn’t stop imme-
diately and a liquid drop was formed at the tip of the needle. With the
following depositions that drop was placed on the top of the gelatin coat-
ing just before the perforation and underwent a sol-gel transition coating
the gelatin (Fig. 2.5). The electronic controller of the injection head has
a suck back option that allows setting a volumetric amount but this op-
tion wasn’t useful in this case. The quantity of liquid that drips from the
needle slightly changed every injection and the suck back couldn’t be set
precisely. For example setting the suck back too high led to an alginate
column with a void at the base in the subsequent injection.
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After postprocessing the sample partially kept its shape, it wasn’t rigid
enough to avoid collapsing on itself after being removed from the PBS
but enough to don’t get destroyed in the process of moving it with a pair
of tweezers. It should be noted that the gelatin was removed just to be
able to observe the alginate without the matrix where it was injected,
eventually the sample could be used with the gelatin directly since gelatin
becomes a liquid at physiological conditions. If the external matrix is
needed for the ﬁnal application this injection system gives the possibility
of using also other hydrogels, for example agarose.
While using this injection system it was possible to observe some short-
coming, some of which could be easily ﬁxed while others were much more
diﬃcult to solve. As already said after each injection a small drop formed
at the tip of the needle that coated the gelatin with the subsequent de-
positions. Increasing the number of injections the coating that formed
got thicker. The coating on the gelatin should be removed from the sam-
ple after the process, a procedure that was diﬃcult to perform without
cutting a portion of the actual sample and decreasing its height. This
was problematic since the possible height of the sample is limited by the
availability of needles with a small diameter on the market. It’s very
diﬃcult to ﬁnd needles with that diameter, or similar, longer than the
one we used (1/2” = 1,27cm). This means that in order to manufacture
a sample bigger than half an inch, more deposition runs are needed, the
depositions must be placed on top of each other and some way must be
found to join them together. It should be pointed out that when the
needle was perforating the gelatin, sometimes, rather than creating a
new hole, it followed the previous one. A longer needle with the same
dimensions as ours will bend even more and this phenomenon would be
likely more marked.
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This printer was set up for a “vertical” (along z) deposition at ﬁxed
x-y positions that can be repeated to create more complex structures.
With this approach it is feasible to produce structures that are composed
only by vertical lines (a spheroid can‘t) while it can be used to form
components of cylindrical structures such as nerve grafts and synthetic
blood vessels.
Another intrinsic limit of this approach is the fact that this is a contact
printing system: the deposition system is in contact by design with the
substrate where the sample is printed. Some issues of the printer like
the possibility of clogging when DMEM is used and the formation of the
unwanted alginate coating on the gelatin matrix are strongly related to
this aspect.
2.6. Conclusions
This simple printing system was a smart approach to cells deposition
since it gave the possibility to entrap cells in a hydrogel and precisely
deposit them using a sacriﬁcial gelatin matrix. The gelatin acts as a
support and, at the same time, can contain the calcium ions needed to
crosslink the alginate. The samples obtained can be moved directly to
physiological conditions without the need of further postprocessing. The
setup of the printer allows the formation of vertical hollow structures.
However the aforementioned shortcomings pushed us to move towards
another direction, to a contactless more versatile printer, but keeping
some feature of this injection system.
The injection into gelatin was abandoned after observing its shortcom-
ings in favor of electro hydro dynamic printing. For this reason the
injection in gelatin method was not deeply characterized. Furthermore
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the injection in gelatin was developed for a speciﬁc application while the
electro dynamic printing has wide potential applications when a precise
deposition of a cell laden hydrogel is needed.
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Figure 2.5.: Top: Parallelepiped constituted by 120 injection, base is 3
mm x 3mm. Bottom: parallelepiped constituted by 180 injections base
is 3 mm x 4.5 mm. (hydrogel formed starting from a DMEM solution).
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Figure 2.6.: Alginate sample after postprocessing. Left: sample inside
the warm PBS bath. The upper part marked as A is the parallelepiped
injected while the lower part B is a residue of the injection process.
Right: Sample removed from the bath.
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3. Cells Encapsulation
This chapter covers the encapsulation process of cells, the printer pre-
sented in the next chapter is based on this process.
3.1. Overview
Cell encapsulation aims at entrapping living cells withing a semi perme-
able matrix, it’s an attractive procedure for a variety of applications in
biotechnology. Encapsulation partially isolates cells from the outside en-
vironment by means of a semipermeable matrix which physically blocks
objects or molecules larger than a critical size while allowing the transit
of small sized molecules.[96]. This characteristic is interesting since it’s
possible for example to transplant non autologous cells needed for a spe-
ciﬁc therapy and physically blocking the host immune system in order to
avoid the use of immunosuppressants drugs and, as a consequence, their
unwanted eﬀects [94, 12]. Encapsulation techniques have been investi-
gated to treat a wide variety of endocrine diseases such as diabetes [24],
anemia [63] and dwarﬁsm [16], but the potential of the technique has
been tested also in diﬀerent applications such as the creation of micro
environments for cells to mimic a tumor [46], to maintain undiﬀerenti-
ated embryonic stem cells for long periods of time [87], or as a source of
growth factors [42].
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One eﬀective method to produce capsules containing cells is the Electro
Hydro Dynamic process (EHD). If an aqueous polymer solution contain-
ing cells is pumped, these will be entrapped in the solution drops that
are ejected from the needle against a target of opposite voltage [38].
Moreover, if the target is a liquid that reacts with the polymer solution
and induces its sol-gel transition, the drops become gelled beads with
entrapped cells. This technique has been exploited to entrap several
molecules inside diﬀerent materials, such as chitosan, polylactic acid and
polycaprolactone. For instance, Xu and Hanna [103] prepared spherical
bovine serum albumin loaded chitosan capsules showing that the ﬁnal
capsule size was strongly inﬂuenced by the ﬂow rate, and Xu et al. [104]
entrapped bovine serum albumin in polylactic acid analyzing the eﬀect
of polymer concentration on the geometrical features of the beads while
Ding et al. [27] studied Taxol-loaded polycaprolactone beads showing the
ability to manufacture highly loaded monodispersed beads.
This technique can be applied to manufacture complement compatible
cell-laden microcapsules using alginate [78], a polymer commonly used
for microencapsulation of therapeutic agents [34, 41, 92] and by far the
most studied material for encapsulation of living cells [64, 93, 81, 44, 9].
Alginate is both a biopolymer and a polyelectrolyte. It’s considered to
induce a low immunogenic response, it’s degradable with degradation
kinetics that can be chemically tuned [106, 48].
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3.2. Electro hydro dynamic encapsulation
3.2.1. Introduction
In this study we encapsulated B50 neuroblastoma rat cells in a thick al-
ginate coating to determine the bead size compatible with cells survival
considering the limited transport of nutrients with depth. Based on these
results we encapsulated cells in beads using the EHD process and eval-
uated the eﬀect on the geometrical parameters of the beads not only of
the inner diameter of the needle, the concentration of the polymer and
the voltage applied but also the density of cells in the alginate solution.
By using a software for automated biological image processing that relies
on solid algorithms for image analysis we were able to measure the diam-
eter, eccentricity and form factor of the beads. We assessed the viability
of cells inside the beads, and their behavior when reseeded on a tissue
culture plate after being released from the capsules with a technique that
only involves washes in a phosphate buﬀer solution, without the need of
citrate [56] or chelating agents
3.2.2. Materials
Alginic acid sodium salt from brown algae (alginate) and calcium chlo-
ride dihydrate were purchased from Sigma-Aldrich (USA). Calcein-AM,
Propidium Iodide (PI), Phosphate buﬀered saline without calcium and
magnesium (PBS) and Dulbecco’s modiﬁed eagle medium (DMEM) were
purchased from Invitrogen (USA). Needles of the electrospraying appa-
ratus were made of type 304 stainless steal and were purchased from
Hamilton (Bonaduz/Switzerland), three kinds of needles were used :
gauge 22S (Outer Diameter: 0.718 mm, Inner Diameter: 0.168 mm),
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gauge26S (O.D.: 0.474 mm, I.D.:0.127 mm), gauge 33 (O.D.: 0.210 mm,
I.D.:0.108 mm). Neuroblastoma B50 cell line was purchased from the
Istituto Proﬁlattico Sperimentale, Brescia, Italy.
3.2.3. Methods
3.2.3.1. Preparation and sterilization of alginate and crosslinking
solution
Alginate powder was dissolved under mild stirring in PBS for 8 hours
at room temperature to obtain alginate solutions at the desired concen-
tration (1% wt/vol, 1g/100ml; 2% wt/vol, 2g/100ml). A syringe ﬁlled
with the solution was connected to a pump to be ﬁltered through a 0.22
µm ﬁlter under sterile conditions overnight and immediately used after
ﬁltration. The crosslinking solution consisted in calcium chloride dihy-
drate dissolved into distilled water at a concentration of 400 mM, ﬁltered
through a 0.22 µm ﬁlter under sterile conditions.
3.2.3.2. Preparation of alginate solutions containing cells
About one million of B50 rat neuronal cells were defrozen and expanded
by using standard protocols. In particular, cells were seeded for 24 h
in a 25cm2 ﬂask using DMEM containing 2mM L-Glutamine and 10%
Fetal Bovine Serum (Gibco) as culture medium. Then cells were washed
in PBS to remove residues of dimethyl sulfoxide left from the freezing
solution. At sub conﬂuence (80%) cells were detached from the ﬂask
with 0,05 % Trypsin/EDTA (Euroclone) and reseeded in a bigger ﬂask
(175 cm2) till conﬂuence, subsequently cells were detached and moved to
a 15 ml vial. Cells inside the vial were centrifuged at 1000 rounds/min
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for 10 minutes, the supernatant was removed, and cells were accurately
washed with PBS to remove any residues of culture medium since it
contains some cations (ex. Ca2+) that could crosslink the alginate in
a non-controlled way and centrifuged again. Cells on the bottom of the
vial were dispersed in the PBS by vibration and an aliquot of the solution
was taken to count the number of cells using a Cellometer Auto T4 and
Trypan Blue 0,4% (Invitrogen) as contrast agent. Cells were centrifuged
again, the supernatant was removed and the right amount of alginate
solution was added to obtain an alginate solution containing cells with
the desired cell concentration (5 and 10 millions cells per milliliter of
solution). DMEM, PBS , Trypsin/EDTA and the alginate solution used
had been warmed at 37°C before use.
3.2.3.3. Cell entrapment in alginate coating
Under a biologic hood about 6 ml of alginate solution containing 30
millions cells was poured on the bottom of 6 wells of a 24 well plate (1
ml of alginate with 5 millions cells per well), the well was ﬁlled with the
crosslinking agent and left at room temperature for 20 minutes. The
crosslinker was removed with a pipette and the hydrogel obtained was
washed three times in culture medium. Due to shrinking the hydrogel
samples were not perfectly round and their diameter was between 12 and
16 mm. Finally they were moved to an incubator ( 37°C, 5% C02) inside
a 6 well plate containing culture medium. A 6 well plate was chosen to
allow a bigger volume of nutrient solution compared to the 24 one. The
medium was changed every day up to 7 days.
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3.2.3.4. Cell encapsulation and release
A custom electrically insulated holder was made and placed under a bi-
ological hood (Fig Fig. 3.4 B). A 3 ml syringe was loaded with alginate
solution (or alginate solution containing cells) connected to a polyte-
traﬂuoroethylene tube and placed on the pump set to a ﬁxed ﬂux of 0.05
ml/min, the other side of the tube was connected to a stainless steel
needle and placed in the holder under the hood. The positive electrod of
a generator (ES30, Gamma High Voltage Research Inc, USA) was con-
nected to the needle while the ground was connected to a metallic plate
placed under a Petri dish containing the sterile calcium chloride solu-
tion and placed below the needle at a distance of 5 cm. The pump was
switched on ejecting droplets of cells containing alginate solution from
the needle, that immediately formed gel beads in the calcium chloride
solution. After 10 minutes the calcium chloride solution containing the
gel beads was poured into a 15 ml vial. The vial was mildly centrifuged
to pellet the beads (500 rpm, 30 seconds), the supernatant was removed,
DMEM at 37°C was added and the beads concentrated at the bottom
were dispersed by vibration. The procedure was repeated three times
to ensure the complete removal of calcium chloride. Finally DMEM was
added and the solution containing the beads was moved to an incubator
inside a small ﬂask with a ﬁlter cap.
At ﬁxed times, cells entrapped within the gel were released by dissolving
the gel. The gel was dissolved by ﬁrst removing the DMEM containing
cations with a quick wash in PBS at room temperature and then by
placing it in an incubator with PBS at 37°C, centrifuged and ﬁnally
suspended in medium until seeding.
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3.2.3.5. Geometry of beads
The solution containing the beads was shaken, diﬀerent aliquots were
taken, put on a glass and images of the beads were taken with an opti-
cal microscope (Carl Zeiss Axiotech 100). All images were acquired in
wet state. At least 20 images were taken to have 30 measurements per
experimental point for a total of 2700 measurements (see Fig Fig. 3.5A
and Fig. 3.6).
CellProﬁler [52](Broad Institute, USA), an open source software, was
used to process the images and measure the geometrical parameters of
the beads. The software was conﬁgured after a series of trial and error
tests aimed at minimizing all errors that could arise using an automatic
procedure. Loaded images were ﬁrst converted to gray scale by combining
together the red blue green components in order to enhance the outline
of the beads using the Sobel method [89](computational time of 2.5 s on
a 2.4 GHz processor). This method was able to render higher contrast
white edges on a black background compared to other algorithms as
Prewitt [74](2.5s), much less noisy images compared to Roberts [79](3.1
s) and continuous borders compared to Canny [14](7.8 sec).
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Figure 3.1.: Comparison between the Sobel (left) and Canny (right)
methods for edge enchancing
The output images were processed using the Kapur [44](25s) threshold-
ing method in order to identify the beads (objects) and separate them
from the background. This method was chosen since it gives the most
consistent results among all the other methods tested as Otsu [67] and
Ridler-Calvard [75]. It was applied using an adaptive thresholding since
the illumination was not constant on the picture, clumped objects were
separated by their round shape. Cells were not considered as an object
since the software was setup to ignore smaller entities contained already
in a larger object. The resulting objects of this process (the alginate
beads) were processed further by measuring the biggest and smallest
axes, eccentricity (e) and form factor (ﬀ) which are 0 and 1 respectively
for a perfect circular shape.
This part of the experiment was aimed at ﬁnding the best set up to obtain
spherical monosized beads. Fig. 3.2 shows the typical beads obtain by the
EHD process.
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Figure 3.2.: Alginate beads, geometrical features.
The results of some samples were checked with ImageJ to assess the
validity of the method. In some cases the software failed to recognize
the beads correctly (mostly with clusters of beads together with uneven
illumination) therefore some ad hoc modiﬁcations to CellProﬁler were
done, adjusting the threshold of the Kapur method.
3.2.3.6. Scanning Electron Microscopy
A standard scanning electron microscope (SEM) was used since the cryo
SEM is not available in our laboratory. The preparation of the sample in
absence of a cryo chamber involves the removal of water. The ﬁxation of
cells was problematic given the nature of the samples [2] so we performed
the observations on the hydrogel coating and the beads without cells
since the preparation of the sample would had destroyed the cells. SEM
observations were performed in order to have an idea of the morphology of
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the material the cells would be eventually in contact with. A small piece
of coating was cut for the preparation of the sample while the beads were
used as they were. In order to avoid the formation of big water crystals,
samples were frozen with liquid nitrogen. Some samples were frozen by
placing them on a copper plate in contact with a liquid nitrogen bath to
increase the heat transfer at the interface between the sample and and
the liquid nitrogen. During freezing most of samples fractured while in
the other cases they were fractured manually. Samples were placed on
a stub to be coated with gold and observed with a SEM Supra (Zeiss -
Germany).
3.2.3.7. Confocal microscopy
A live/dead assay using Calcein-AM and Propidium Iodide was per-
formed on the hydrogel coating and on the beads. The supernatant
was removed from the samples with a pipette and new medium with
10% v/v Calcein-AM was added, then the samples were moved to an
incubator and left there for 30 minutes. At the end of the incubation
time the supernatant was removed and the samples were cleaned three
times with calcium chloride before adding a PBS solution with 2% v/v
Propidium Iodide. The samples were left for 3 minutes at room tem-
perature and the washing procedure was performed again. All solutions
used were at 37°C. In the case of beads the above procedure was slightly
diﬀerent since it was necessary to pelletize the beads using a 15 ml vial (
500 rpm, 30 seconds) in order to remove the supernatant. Observations
with the confocal microscope (Nikon A1, Japan) were performed in wet
state, a separate image was taken for each setup, for Calcein-AM a 488
wavelength laser and a 500 to 550 nm detector were used while a 560 nm
wavelength laser and a 570 to 620 nm detector were used for Propidium
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Iodide.
3.2.4. Results and Discussion
3.2.4.1. Confocal Microscopy of Entrapped Cells
Fig. 3.3 was taken by observing the middle part of the hydrogel coating
scanned in depth and then merging all single stacks. Already after 24
hours from encapsulation two distinct regions can be distinguished: one
closer to the surface of the sample that was in contact with the nutrients
solution where most cells are alive (colored in green) and a deeper one
were most cells are dead (colored in red). At 72h the situation is even
more marked, with a dense layer of living cells being conﬁned to the top
250 µm. Starting from these results, we decided to produce beads with
a diameter lower that 400 µm , in order to guarantee the survival of cells
in all the volume of the beads. It’s worth pointing that beads smaller
that 400 µm would be likely needed as cell loading increases since higher
densities of cells could impede diﬀusion of nutrient from the surface to
cells in inner positions. Also, capsules smaller than 300 µm lead to a less
marked immune response from the host compare to conventional size
capsules (300 -1000 µm)[82]
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Figure 3.3.: 5 million B50 cells entrapped in 1 ml of 2% alginate hy-
drogel, live(green)/dead(red) confocal assay after 24 hours (left) and
72 hours (right) after entrapment. Living cells on the top, close to the
nutrient solution. Bar is 200 µm
3.2.4.2. Measurements of beads
The eﬀect of the diameter of the needle on bead geometrical features was
evaluated keeping the ﬂux of material constant. This mean that the total
volume of alginate beads per minute was constant as well as the average
amount of encapsulated cells.
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Figure 3.4.: A) Beads diameter using diﬀerent needles vs Applied volt-
age; G22S ( Outer diameter: 0.718 mm, Inner Diameter: 0.168 mm),
G26S (O.D.: 0.474 mm, I.D.:0.127 mm), G33 (O.D.: 0.210 mm,
I.D.:0.108 mm); dripping zone (a), transition zone (b) and jetting zone
(c) marked for the G33 needle B) picture of holder,
In Fig. 3.4 we reported a typical correlation between voltage and diameter
of the bead. As suggested by Moghadam et al. [60] it is possible to
evidence three main regions: dripping zone (a), transition zone (b) and
jetting zone (c), with the transition zone being characterized by a relevant
increase in the data spreading and standard deviation. It is worth noting
that an increase of the inner diameter of the needle determines an upper
right shift of the graph, which means that a higher voltage is needed to
reach a stable jetting zone because of the presence of a wider dripping and
transition zone and that bigger beads are obtained at a given voltage.
As an example, using the G33 needle (I.D.:0.108 mm), beads with a
diameter consistently smaller than 400 µm could be obtained. With the
G26s needle (I.D.:0.127 mm) the beads formed in the jetting zone had a
diameter very close to 400 µm while with the G22S (I.D.:0.168 mm) the
dripping and transition zone were too wide to observe a stable jetting
zone within the investigated voltages (0 - 10 kV) .
39
Chapter 3 Cells Encapsulation
On the base of these observations it was decided to focus the cell en-
trapping experiments using the needle with the highest gauge (higher
gauges correspond to lower inner diameters) to easily obtain beads with
a diameter consistently smaller that 400 µm. It can be generally noted
that, from applications in vivo for injections and also to bead deposition
with bioprinters, smaller beads are usually preferred to obtain a high
surface to volume ratio, so to enhance any mass transport phenomena
through the hydrogel or to allow easier injections of a solution containing
beads. It’s also important to note that smaller needles induce high shear
stresses on cells, that could aﬀect cell viability and also their ability to
spread and proliferate in cell culture plates after being released from the
alginate capsule.
From Fig. 3.5 it can be generally observed that by increasing cell density,
higher voltage are required to obtain a transition to the jetting zone.
Both for alginate 1% and alginate 2% by increasing the cell density the
transition zone becomes wider and the jetting zone shifts to the right. As
an example in the case of alginate 1% without cells the transition zone
occurs between 4 and 6 kV with a peak in standard deviation at 5KV
while with cells in solution range becomes wider. Zones where the data
scattering start to increase signiﬁcantly fall in the range of 5 and 6KV in
the case of 5 · 106 cells/ml and 4, 5 to 6 kV in the case of 10 · 106 cells/ml
with a wider range of observed diameters. The stable jetting zone was
observed at higher voltages than in the case without cells ( 6 kV vs 5 kV).
Once the jetting zone is reached, by increasing the voltage the process
becomes less stable, there is an increase in standard deviation and the
presence of very small beads with a diameter far from average can be
observed from the appreciable deviation of the bottom line (minimum
values) and the central line (average) in the plots regarding Alginate 1%
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in Fig. 3.6. With a solution of 10 millions cells per milliliter of alginate
and low potentials it was not possible to obtain regular beads (Fig. 3.5D
and Fig. 3.6)
A similar behavior was obtained for alginate 2%: without cells the high
standard deviation was found at 4KV (transition zone) and the stable
jetting zone is reached at 5 kV. By adding cells the high standard devia-
tion range falls between 4 and 5 kV for alginate with 5*10^6 cells/ml at
3, 4 and 5 kV for 10*10^6 cells/ml. Also in this case with the increase
of the cell concentration the voltage required to reach the stable jetting
zone increases. Once the jetting zone was reached a slight increase in
average diameter of the beads was observed when cells were present. It
was possible to obtain beads with constant diameters from 6KV up re-
gardless of the cell density. By analyzing the beads shape in terms of
eccentricity and form factor, it is possible to notice that the presence
of cells induces the generation of a more regular and spherical geometry
Fig. 3.5 A, B and C.
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Figure 3.5.: Beads manufactured with alginate 2% at 9KV containing
(A) no cells, (B) 5 millions cells/ml of alginate and (C) 10 millions
cells/ml; (D) Beads as measurable objects recognized by the software
for Figure A
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Figure 3.6.: Beads diameter vs applied voltage for alginate 1% (left)
and alginate 2% (right). Starting solution containing no cells (top), 5
millions cells/ml (middle) and 10 millions cells/ml (bottom).
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Diameters (µm)
Alginate 1% Alginate 2%
ΔV (kV) No Cells 5 millions 10 millions No Cells 5 millions 10 millions
0 1931 ± 18 1685 ± 22 1851 ± 35 1744 ± 29 1631 ± 41
1 1935 ± 17 1728 ± 42 1567 ± 14 1739 ± 16 1389 ± 20
2 1873 ± 13 1613 ± 9 1502 ± 16 1647 ± 29 1288 ± 17
3 1813 ± 14 1408 ± 13 1383 ± 24 1275 ± 9 1240 ± 12 1022 ± 109
4 1617 ± 20 1104 ± 23 866 ± 113 512 ± 26 760 ± 51 523 ± 103
5 607 ± 161 477 ± 182 615 ± 148 178 ± 2 352 ± 41 290 ± 35
6 175 ± 33 288 ± 160 171 ± 274 175 ± 4 200 ± 9 198 ± 13
7 163 ± 41 187 ± 14 191 ± 8 181 ± 4 195 ± 11 195 ± 9
8 163 ± 41 178 ± 28 185 ± 24 180 ± 4 197 ± 10 197 ± 8
9 165 ± 48 162 ± 30 158 ± 42 166 ± 13 198 ± 9 194 ± 6
10 149 ± 46 138 ± 27 142 ± 45 177 ± 4 192 ± 6 192 ± 5
Eccentricity and Form Factor
Alginate 1%
ΔV (kV) No Cells 5 millions 10 millions
Eccentricity Form Factor Eccentricity Form Factor Eccentricity Form Factor
7 0.21 ± 0.07 0.70 ± 0.23 0.22 ± 0.06 0.81 ± 0.06 0.24 ± 0.08 0.78 ± 0.10
8 0.21 ± 0.08 0.74 ± 0.20 0.21 ± 0.09 0.80 ± 0.14 0.22 ± 0.06 0.79 ± 0.12
9 0.20 ± 0.07 0.77 ± 0.21 0.23 ± 0.06 0.73 ± 0.17 0.21 ± 0.08 0.79 ± 0.17
10 0.23 ± 0.09 0.72 ± 0.21 0.27 ± 0.12 0.74 ± 0.21 0.25 ± 0.08 0.75 ± 0.16
Alginate 2%
ΔV (kV) No Cells 5 millions 10 millions
Eccentricity Form Factor Eccentricity Form Factor Eccentricity Form Factor
7 0.41 ± 0.11 0.81 ± 0.07 0.18 ± 0.06 0.84 ± 0.06 0.23 ± 0.07 0.85 ± 0.03
8 0.40 ± 0.13 0.79 ± 0.14 0.24 ± 0.09 0.84 ± 0.06 0.24 ± 0.09 0.77 ± 0.15
9 0.39 ± 0.12 0.85 ± 0.04 0.22 ± 0.06 0.85 ± 0.03 0.22 ± 0.06 0.79 ± 0.13
10 0.40 ± 0.13 0.76 ± 0.17 0.27 ± 0.07 0.84 ± 0.04 0.27 ± 0.07 0.83 ± 0.07
Table 3.1.: Diameter , eccentricity and form factor for beads manufac-
tured with a solution of alginate 1% and alginate 2% using a gauge 33
needle. In bold the best experimental setup: high circularity and low
dispersion of values.
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3.2.4.3. Scanning electron microscopy
A preferential direction of pores can be clearly seen from Fig. 3.7 and we
believe that it’s likely to be the eﬀect of the preparation of the sample
due to its high initial water content. In fact it’s possible to observe pores
in the same direction of the temperature gradient established during
freezing: from the inner part of the sample to the external surface. The
sublimation of the water crystals leaves a porous directional structure.
Figure 3.7.: SEM images of cryo fractured alginate coating
The same situation is also present using capsules. In this case, as shown
in Fig. 3.8, some capsules didn’t fracture during their preparation. Due
to preparation, capsules partially lose their spherical features presenting
a corrugated and irregular surface. An external skin is formed that some-
times detaches from the bulk. We believe that it could be due to how
alginate crosslinks, starting from the external surface being the ﬁrst in
contact with the divalent cations when the solution is placed in the cal-
cium chloride bath. In fact, if the drops of alginate are removed soon after
being placed in the bath, a hydrogel skin forms but their bulk remains
liquid. If the beads are kept for longer time in the bath also the bulk un-
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dergoes a sol-gel transition. We think that as soon as the liquid drops are
submerged in the bath a quick crosslinking reactions occurs that forms
the hydrogel skin and after that cations diﬀuse inside the bead, slowed
down by the external hydrogel that acts as a diﬀusional barrier. It’s
reasonable to think that this forms a strongly bound external skin that
binds more weakly to the bulk leading to an easy detachment after the
preparation of the sample.
Figure 3.8.: SEM images of the alginate capsules
In few cases pores didn’t completely ﬁll the surface of the fracture and
as shown in Fig. 3.9, it was possible to observe what seems the actual
morphology that characterizes the hydrogel: a three dimensional network
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with submicron pores. It’s worth noting that, based on their phenotype,
cells can have a wide range of dimensions but typically they are bigger
than 5-10 µm in their inactive state.
Figure 3.9.: SEM images of alginate morphology
The scanning electron microscopy for hydrogel was performed since it’s
quite common to ﬁnd this procedure in literature applied to hydrogels.
However in our case it was problematic since it’s diﬃcult to state ﬁrmly
that a particular morphology is not due to the preparation of the sample
and in particular to the ice crystals formed given the initial high water
content.
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3.2.4.4. Confocal Microscopy of encapsulated cells
Figure 3.10.: Confocal Live/Dead assay (Green/Red) of encapsulated
B50 cells , 5 millions cell per ml of alginate, using EHD at 9KV, 5 cm
from target. A) Alginate 1% after 1 day, B) Alginate 2% after 1 day,
C) Alginate 1% after 7 days, D) Alginate 2% after 7 days. Bar is 100
µm
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For the confocal observation we chose to observe the cells inside beads
smaller than 400 µm, as close as possible to be mono sized and as similar
as possible to a sphere (low standard deviation, minimum diﬀerence be-
tween the maximum and minimum diameters observed, low eccentricity
and high form factor). The best candidates were beads manufactured at
9KV using alginate 2% with 5 millions cells per milliliter and they were
compared to beads manufactured using alginate 1% and the same setup
to evaluate if diﬀerent polymer densities have a role in cell viability inside
the beads.
Diﬀerent from the previous case, Fig. 3.10 shows alginate beads contain-
ing mostly living cells with few dead cells. Cells were evenly distributed
inside the beads with a small tendency to aggregate in the middle. We
also observed an increase in the signal after 7 days. It must be noted that
when cells are mixed with the alginate solution some bubbles are formed
so it’s not possible to speculate if cells are able to proliferate inside the
actual hydrogel or if they proliferate by ﬁlling the air bubbles formed
during the mixing procedure.
3.2.4.5. Cell Release
Cells were cultured inside the beads for 1 and 7 days, about 1 million cells
were released and reseeded in a culture ﬂask, images were taken after 3
hours from release and, when possible, every 12 hours after that. Cells
were able to re-attach and proliferate on the tissue culture ﬂask. In both
cases after 3 hours cells attached randomly on the surface however after
72 hours cells conﬁned in the beads for 7 days showed a diﬀerent behavior
than those conﬁned inside the beads for only 1 day. Cells encapsulated
for one day spread evenly on the surface showing a behavior similar to
a standard defrost as shown in Fig. 3.11 A, while cells encapsulated for
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7 days showed a much stronger tendency to form clusters as shown in
Fig. 3.11 B.
Figure 3.11.: Released cells from alginate 2% beads cultured on tissue
culture dish, picture taken 3 (above) and 72 hours (bottom) after re-
lease, encapsulated for 1 (A,C) and 7 days (B,D). Bar is 250 µm
In this case, after seeding, cells migrate to form clusters leaving large
portions of completely cell free tissue culture plate. In contrast to cells
encapsulated for 1 day, cells encapsulated for 7 days couldn’t reach con-
ﬂuence, with the progression of the cell culture small clusters grew and
coalesced together however bigger cluster did not and a complete con-
ﬂuence could not be observed. Moreover there is the presence of some
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sediments that look like acellular constructs.
Figure 3.12.: Conﬂuence of cells encapsulated for 1 day on the left, cells
encapsulated for 7 days unable to reach conﬂuence on the right. Bar
is 500 µm
Other experiments made later on with a diﬀerent batch of cells, diﬀerent
cell lines (human MRC5 and mouse 3T3 not tumoral) and with diﬀerent
needles of higher inner diameter conﬁrmed this behavior (data not re-
ported), it seems that longer encapsulation times trigger some diﬀerent
cell behavior once they are released even if they maintain their ability to
attach and proliferate on the tissue culture dish. It’s worth noting that
the same amount of cells was initially released from the beads and re-
seeded in the same conditions. This kind of behavior was not previously
reported in any experiment concerning cell encapsulation and we believe
that it is important to understand since it could lead to unwanted cell
behavior. We are currently investigating to fully understand its possible
long term implications.
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Figure 3.13.: Beads and released cells, beads were partially treated with
PBS, some beads dissolved and released the entrapped cells
3.2.5. Conclusions
The electro hydro dynamic system has been proved to be a versatile
and eﬀective way to encapsulate living mammalian cells in alginate. It
is versatile since the geometrical characteristics of the obtained beads
can be tuned by easily changing some parameters such as cell density
in solution, applied voltage and diameter of the needle. It is possible
to obtain capsules very close to monosized and with a spherical shape.
Cells inside the capsules remain alive after the encapsulation process and
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maintain the ability to reattach and proliferate on a tissue culture dish
after being released. Cells encapsulated for a few days demonstrated a
diﬀerent behavior than control cells.
3.3. Electro hydro dynamic encapsulation:
more biological evaluations
3.3.1. Introduction
In the previous experiments we characterized a process that leads to the
formation of capsules containing living cells. Thanks to that charac-
terization we found the best parameters of the process to obtain mono
dispersed spherical beads. We found that cells were alive and could reat-
tach to the tissue culture plate once released. In this section a deeper
biological evaluation is presented.
We used B50 which is a tumor cell line with a quick metabolism and a
high proliferation rate, this allowed us to obtain a high number of cells
needed for the experiments in a short time. It should be noted that a full
175 cm2 ﬂask contains about 20 millions cells which are used with 4 and
2 ml of alginate to obtain the concentrations of cells needed. Cells are
detached with 3ml of Trypsin/EDTA and after 3 minutes, as standard
protocols suggest, 12 ml of DMEM are added to deactivate the Trypsin,
leading to 15 ml of solution that is poured inside a vial of equivalent
volume. After stirring, alginate is added and the solution is moved to
a Petri dish for an easier ﬁlling of the 3 ml syringe. All these passages
must be performed quickly in order to minimize the total time needed
for encapsulation because of the presence of living cells that need speciﬁc
environmental conditions. Alginate is a viscous solution that needs some
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time to ﬂow (when poured from a vial for example) so, given the time
constraints and the many steps needed to prepare the syringe for the EHD
encapsulation, about 1 - 1.5 ml of alginate are lost in the process. For
this reason a cell line with high proliferation rate was initially preferred.
Tumor cells are usually much more resilient than non tumor cells further-
more their behavior after stress could be diﬀerent due to their diﬀerent
gene proﬁle. So we did some biological evaluation on other cell lines to
have a more complete understanding of the eﬀect of the encapsulation
through the EHD process. In these experiments we also used non tumor
3T3 mouse ﬁbroblasts, and MRC5 human ﬁbroblasts.
The evaluations in this section were performed on beads manufactured
with the EHD process at 9KV with gauge 33 needle, starting from a 2%
alginate solution containing 5 millions cell per milliliter. The results of
the characterizations were compared to a standard cell culture as control
and on a cell culture on an alginate coating to rule out the eﬀect of
the material. We also performed tests on cells inside the beads and
on cells released from the beads. This way it was possible to obtain
speciﬁc information on the eﬀect of the encapsulation process on cells,
the response of cells induced by their entrapment inside the capsule and
once released from it.
We evaluated cell viability with AlamarBlue®, DNA content with PicoGreen®
and the productions of two proteins (GAPDH, HSP70) with western blot
using speciﬁc protein markers (antibodies).
In the next sections a brief explanation of the biological evaluation meth-
ods used will be presented.
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3.3.1.1. Cell viability
AlamarBlue® (Resazurin) is a quantitative assay aimed at evaluating
cells viability, that is their ability to live and develop. Resazurin, a non
ﬂuorescent indicator dye, is reduced by cells to resoruﬁn, making it useful
to asses cell mitochondrial activity. Resoruﬁn is red–ﬂuorescent and its
presence can be assessed with a spectrophotometer. Viable cells contin-
uously reduce resazurin to resoruﬁn while damaged and nonviable cells
have lower metabolic activity generating a proportionally lower signal.
AlamarBlue® is a non destructive test, resazurin isn’t toxic and thus it’s
possible to perform more assays on the same sample.
3.3.1.2. DNA quantiﬁcation
PicoGreen® is an assay aimed at quantifying the amount of DNA present
in a sample, a synthetic dye binds speciﬁcally to DNA forming a ﬂuores-
cent complex. Using a standard solution of DNA with known concentra-
tion it’s possible to obtain a calibration curve to compare the ﬂuorescent
emissions and quantify the amount of DNA present.
3.3.1.3. Western Blot
It’s an analytic technique used to detect and visualize proteins contained
in a cellular lysate. Proteins are ﬁrst separated by their molecular weight
with electrophoresis. Proteins are then transferred onto a membrane
where they are stained using speciﬁc antibodies. Typically, a primary
antibody is used to bind to the speciﬁc protein, then a secondary anti-
body bound with a dye targets the primary antibody forming a complex
that can be visualized.
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GAPDH is a protein responsible for many functions in the cellular metabolism
[86], Phadke et al. [73] state that it acts at the interface between stress
factors and the cellular apoptotic machinery, it’s overproduced in tumor
cells [97]. It’s a housekeeping protein, as is β-actin, and is commonly
employed as a standard with the assumption that its production level re-
mains relatively constant in diﬀerent experimental conditions. However
in hypoxia condition its production is increased up to 70% [108, 6].
HSP70 (Heat Shock Protein) is a housekeeping protein overproduced by
cells under stresses [22, 101]. The upregulation of this protein is part of
the heat shock response. Its overproduction is triggered by environmental
stress conditions such as hypoxia, starvation and exposure to toxins.
3.3.2. Materials
Alginic acid sodium salt from brown algae (alginate) and calcium chlo-
ride dihydrate were purchased from Sigma-Aldrich (USA). Phosphate
buﬀer saline without calcium and magnesium (PBS), Dulbecco’s mod-
iﬁed eagle medium (DMEM), Quant-iTTM PicoGreen® dsDNA Assay
Kit, AlamarBlue®, Triton-X 100 0,05% were purchased from Invitrogen
(USA). Proteinasi K was purchased from Qiagen. Guage 33 needle of
the electrospraying apparatus was made of type 304 stainless steal and
was purchased from Hamilton (Bonaduz/Switzerland). Neuroblastoma
B50, 3T3 mouse ﬁbroblasts and MRC5 human ﬁbroblasts cells line were
purchased from the Istituto Proﬁlattico Sperimentale, Brescia, Italy.
3.3.3. Methods
Some assay must be performed directly on cells that must be separated
from the substrate. From both the control plate and the alginate coat-
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ing the medium was collected then the samples were washed, before de-
taching the cells with Trypsin/EDTA. All the solutions were stirred to
pelletize the cells on the bottom of the vial. For the alginate beads a
previously described protocol was used, in brief beads were washed in
PBS at room temperature and then placed in an incubator with PBS at
37 °C. Finally the cells were collected after stirring.
The set up of the experiments was optimized to take into account a
lot of variables that could aﬀect cell behavior and this led to a rather
complicated scheme that is shown in simpliﬁed form in Tab. 3.2.
Table 3.2.: Scheme of experimental procedure
In brief two controls were used, cells seeded in a well plate (referred
simply as control in the next paragraphs) and cells seeded on the alginate
coating. To asses the eﬀect of the encapsulation process some assays were
performed with the cells inside the capsule then some of the capsules of
the same batch were dissolved and the cells obtained were reseeded. The
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exact procedure followed was a consequence of the assay performed, for
example in AlamarBlue® it’s possible to assess the vitality of the cells
inside the beads while for the western blot cells must be released to obtain
their lysates.
3.3.3.1. Cell viability
Samples were incubated in a 48 well plate protected from light for one
and a half hours with a 15% solution of AlamarBlue® in DMEM. The
incubation time was decided after a preliminary experiment. After the
incubation, 100 µl of supernatant were placed in a 96 well plate, 3 well
plates were ﬁlled for each sample. Finally the samples were placed in a
spectrophotometer and scanned. The eﬀect of the alginate on the mea-
sured values was tested by performing the assay on an alginate coating
and the empty beads comparing the results with a blank.
3.3.3.2. DNA quantiﬁcation
Tryton-X was added to the cells, the solution was transferred to an Ep-
pendorf where it was sonicated. The solution was diluted 1:10 with TE
buﬀer and measured with the spectrophotometer.
3.3.3.3. Western Blot
About 1 million of B50 cells were collected and washed from each sam-
ple before being resuspended in a standard lysis buﬀer and centrifuged
at 4°C( 16000 rpm/20 minutes). The ﬁnal concentration of the proteins
was measured with a NanoDrop. NuPage® buﬀer and reducing agents
were added and the samples were kept at 70°C for 10 minutes. The solu-
tions were then placed on the channels of a hydrogel for electrophoresis
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together with a protein standard (pure GAPDH and HSP70 respectively)
and the electrophoresis was started. The proteins were then transferred
on a membrane where they were incubated at 4°C overnight with the
primary antibody following standard protocols, cleaned and incubated
for two hours with the secondary antibody.
3.3.3.4. Confocal images
The pictures were taken on beads loaded with 5 millions cell per milliliter
of alginate following standard protocols (already described)
Note on signiﬁcance
In order to avoid an excessive number of symbols, on some graphs only
the non signiﬁcant values are marked
3.3.4. Results and discussion
3.3.4.1. Cell viability
As expected, the metabolic activity of B50 cancer cells on control well
plate was overall higher compared to the other two cell lines evaluated,
as shown in Fig. 3.14. At day 2 conﬂuence was already reached and
this could explain the lower metabolic activity at day 3 due to contact
inhibition. Like B50, 3T3 had a spike of metabolic activity at day 2 that
signiﬁcantly increases at day 3. On the other hand MRC5 had a constant
metabolic activity that increased signiﬁcantly only at day 3, 1 day later
than the other two cell lines observed.
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Figure 3.14.: Cell viability, well plate control.
The following three graphs compare the metabolic activity of the diﬀer-
ent cell lines seeded on the alginate coating and encapsulated inside the
beads. All cell lines were inﬂuenced by the presence of alginate having
a lower metabolic activity compared to control. Furthermore in all cases
there is a lower metabolic activity inside the beads compared to the algi-
nate coating that decrease with time indicating a possible quiescent state
of cells when entrapped.
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Figure 3.15.: Cell viability for B50, comparison between alginate sub-
strate and beads.
As shown in Fig. 3.15 for B50 the diﬀerence in viability between cells on
the alginate coating and inside the beads is signiﬁcant but not so marked
as with other cell lines, especially at day 0 there is a relatively small
diﬀerence that grows with time.
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Figure 3.16.: Cell viability for 3T3, comparison between alginate sub-
strate and beads.
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As shown in Fig. 3.16 3T3 have a similar trend compared to B50, in this
case the diﬀerence between the viability of cells on the coating and inside
the beads is more marked
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Figure 3.17.: Cell viability for MRC5, comparison between alginate
substrate and beads.
Diﬀering from the other two cases, MRC5 (Fig. 3.17) cells entrapped in
the beads have a very weak signal. In this case the maximum values
are not at day 2 like in the other two cases, after day one the metabolic
activity decreases.
It should be noted that it’s possible that the alginate bead acts as a
diﬀusional barrier for resoruﬁn slowing its supply in the limited time
window of the incubation and, as a consequence, its metabolization by
cells. However, as clearly proven by the B50 and 3T3 graph, resoruﬁn
can be metabolized if cells are inside the beads and if this limiting eﬀect
is actually present there is likely to be the same eﬀect for all three cases.
In fact, if we compare B50 and MRC5 cell lines, MRC5 show a much
more limited viability when entrapped that when seeded on the alginate
coating. This means that inside the beads, MRC5 cells seem to be in
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a state characterized by a lower viability also due to their entrapment
state and not only because of the presence of the material.
The following graphs show the trend in metabolic activity after releasing
cells that were encapsulated for 1 (ﬁrst value post reseeding is D3) and 7
days (ﬁrst value post reseeding is D8). Cells were counted before seeding
and for this reason this test take also into the account the eﬀect on the
overall metabolic decrease due to the cells that didn’t reattach.
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Figure 3.18.: after 1 day of encapsulation on the left, after 7 days of
encapsulation on the right. Signiﬁcance only for values post reseeding
B50 encapsulated for 1 day were able to regain the initial metabolic ac-
tivity of control immediately after reseeding, in fact as shown in Fig. 3.18
already at D2 the signal is higher than the signal for control cells at D0.
When encapsulated for 7 days the recovery is slower and one more day
is needed to regain the initial viability
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3T3 Reseeded - 7 days in capsules
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Figure 3.19.: 3T3 Reseeded after 1 day of encapsulation on the left,
after 7 days of encapsulation on the right. Signiﬁcance only for values
post reseeding
3T3 have a similar trend to B50, as show in Fig. 3.19 with an immediate
recover if encapsulated for one day and a recovery delay of one day if
encapsulated for seven.
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MRC5 Reseeded - 7 days in capsules
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Figure 3.20.: MRC5 Reseeded after 1 day of encapsulation on the left,
after 7 days of encapsulation on the right. Signiﬁcance only for values
post reseeding
MRC5, in contrast to the other two cell lines needed more time to recover
their viability. In fact cells encapsulated for 1 day couldn’t recover the
initial metabolic activity completely after 3 days since release. Cells en-
capsulated for 7 days needed another week to regain a metabolic activity
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comparable to control.
It’s clear that all cell lines were aﬀected by the encapsulation process,
in particular human ﬁbroblasts MRC5. Longer encapsulation times have
a more marked impact on the sample to recover their initial metabolic
ability. However this ability can be recovered and can become comparable
to control even if longer times are needed.
3.3.4.2. DNA quantiﬁcation
Fig. 3.21 shows the normalized number of cells inside the beads up to day
3. It’s possible to observe a marked increase of cells in the case of B50,
at day 3 the number of cells is more than double compared to D0. This
conﬁrms the previous observations on B50 with the confocal microscope
where an increase of number could be observed (Fig. 3.10). 3T3 follow
a similar trend but their number at day 3 only increases of a fraction of
the initial number of encapsulated cells. The number of MRC5 remain
constant, slightly but signiﬁcantly decreasing at day 3. There is a relation
with the viability assay, showing that a high metabolism of cells allows
proliferation inside the beads (B50) while a lower metabolism doesn’t.
(MRC5)
65
Chapter 3 Cells Encapsulation
Beads
B50 3T3 MR
C5
0
1
2
3 D0
D1
D3
p<0.05
£ D0 vs D1
$ D0 vs D3
& D1 vs D3
$
&
$
$
&
£
£
Nu
mb
er
of
ce
lls
(no
rm
aliz
ed
)
Figure 3.21.: Number of cells inside the beads, normalized to the num-
ber of cells at D0.
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3.3.4.3. Confocal Microscopy
Figure 3.22.: Live/Dead assay: 3T3 Cells, top day 1, bottom day 7.
On the left confocal image with green living cells, on the right optical
image.
The confocal observations of 3T3 and MRC5 cells conﬁrmed the viability
of cells as was previously shown for B50. The signal seems weaker than
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that from B50 in the case of cells encapsulated for 7 days and since the
green dye must be metabolized by cells this could be a clue that longer
encapsulation times put cells into a lower metabolic state. However cells
remain viable.
Figure 3.23.: Live/Dead assay: MRC5 Cells, 1 and 7 days
3.3.4.4. Western Blot
The results of the western blot were unexpected and are presented just as
reference and for discussion. Gapdh is a house keeping protein used as a
standard since in non hypoxia conditions its concentration is constant in
cellular lysates. We initially tested the production of gapdh to set up a
protocol for the western blot given the complication arising from working
with encapsulated cells and obtaining lysates from them. A constant
or increased level of gapdh when cells were in hypoxia conditions, was
expected. However in the presence of alginate, the production of gapdh
appeared lower.
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A lower production of gapdh is expected at D0 since cells still have to
activate its production but wasn’t expected at the following experimental
times for example in the case of alginate coating and beads at day 1
(column 8 and 9)
1. control
2. control
3. control
4. D0 control
5. D0 coating
6. D0 beads
7. D1 control
8. D1 coating
9. D1 beads
10. D3 control
11. D3 coating
12. D3 beads
13. D5 control
14. D7 beads
15. cells release at D0 and re-
seeded for 5 days
16. cells release at D1 and re-
seeded for 5 days
17. cells release at D3 and re-
seeded for 5 days
18. cells release at D7 and re-
seeded for 5 days
19. control
20. control
21. control
Figure 3.24.: Western blot of MRC5 cells, Gapdh marker
The same eﬀect occurred for hsp70, with a marked decrease in production
in the aforementioned columns.
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1. control
2. control
3. control
4. D0 control
5. D0 coating
6. D0 beads
7. D1 control
8. D1 coating
9. D1 beads
10. D3 control
11. D3 coating
12. D3 beads
13. D5 control
14. D7 beads
15. cells release at D0 and re-
seeded for 5 days
16. cells release at D1 and re-
seeded for 5 days
17. cells release at D3 and re-
seeded for 5 days
18. cells release at D7 and re-
seeded for 5 days
19. control
20. control
21. control
Figure 3.25.: Western blot of MRC5 cells, Hsp70 marker
It should be noted that cells are extracted from the beads by dissolving
the alginate using PBS and stirring the solution to pellet the cells. The
supernatant is removed, cells are washed and then a lysate is made or
they are reseeded. We believe it’s possible that alginate is not completely
removed during this procedure interfering with the movement of the pro-
teins in the electrophoresis run and leading to unexpected results in some
columns. A similar situation could also justify the results referred for the
alginate coating.
For example comparing control at column 10 and alginate coating at
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column 11 it seems that the production of hsp70 on top of the alginate is
much lower. The production seems even lower for cells encapsulated in
the beads for three days in column 12 having a line barely recognizable
on the membrane.
Figure 3.26.: MRC5, nuclei (blue) and cytoskeleton (red) on the left,
nuclei (blue) and hsp70 (green) on the right. MRC5 cells grown on
alginate coating, day3.
The confocal picture (Fig. 3.26) taken at the same experimental time of
column 11 after immunostaining shows that the protein is indeed present
in the cells when cultured on the alginate coating. While Fig. 3.27 shows
the situation corresponding to column 10, the control, where more cells
are present, as expected.
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Figure 3.27.: MRC5, nuclei (blue) and cytoskeleton (red) on the left,
nuclei (blue) and hsp70 (green) on the right. MRC5 cells grown on
control well plate, day3.
Comparing the two pictures, even if confocal microscopy is not a quan-
titative observation, it’s diﬃcult to explain the barely visible line in the
western blot for column 11. This is a clue that the results of the western
blot could be misleading.
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Figure 3.28.: MRC5, nuclei (blue) on the left, hsp70 (green) on the
right. MRC5 entrapped in beads, day3.
3.3.4.5. Conclusions
These observations proved that cells were alive inside the beads even
if their metabolism is slowed down, however it can be regained after
reseeding. There was a diﬀerence in how cells respond to the encapsula-
tion treatment, cells with a higher natural metabolism had, as expected,
a less marked decrease in activity inside the beads and a faster recovery
once released. Cells with a slower natural metabolism took more time to
recover from encapsulation but their activity was not adversely aﬀected.
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3.4. Addendum: EHD Co-encapsulation of
gelatin in alginate
3.4.1. Introduction
Once the cells are encapsulated in alginate they are uniformly distributed
inside the hydrogel. This could limit the natural cell-cell interaction, the
production of extra cellular matrix (ECM) and the interaction between
cells and ECM which are fundamental for the reconstruction of a func-
tional tissue in vitro [13, 105]. Alginate was chosen as the basic material
for this thesis because there is a consistent amount of scientiﬁc literature
dealing with its chemical modiﬁcation and the tuning of its degradation
kinetics without modifying drastically its ability to form gels.[50, 51, 36].
The tunable degradation of alginate could leave room for cells to build
their own extracellular matrix until the alginate support is completely
gone.
This section represents an attempt to set up an encapsulation process
that leads to capsules containing small clusters of tissue [59] without
relying on the degradation of alginate. The idea behind this attempt was
to use gelatin as the encapsulation matrix of cells and then encapsulate
the gelatin beads in alginate. This way the gelatin would become a
liquid at physiological conditions and cells would be entrapped in the
empty volume left by the gelatin beads inside the alginate leading to an
alginate capsule containing small clusters of cells or maybe small clusters
of functionalized tissue.
Gelatin is a complicated material to work with especially if the goal,
like in this case, is to develop a protocol for cell encapsulation. Gelatin
undergoes a sol-gel transition during cooling at about 35°C while cells
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shouldn’t be at temperature above 39-40°C to avoid damage leaving a rel-
atively small window of 5°C degrees to work in. In fact the ﬁrst attempt
to create gelatin capsules was by using a metallic sieve as a mold to shape
the hydrogel and then remove the capsules formed with a jet of nitrogen
gas. Initially this method was developed for alginate with the idea of
moving to gelatin once a protocol could be established. This method
failed and tests with living cells were not performed. Subsequently an-
other methods involving a water in oil emulsion was tested and gelatin
capsules containing cells could be produced. Capsules created this way
were encapsulated through the electro hydro dynamic process and ob-
served with the confocal microscope. Overall the co-encapsulation using
these two materials and methods here described had a lot of shortcomings
and led to unexpected results.
This section describes a procedure that had potential but ﬁnally failed
and it was abandoned after some months of work. For this reason it’s
only brieﬂy described in following sections.
3.4.2. Materials
Alginic acid sodium salt from brown algae (alginate), calcium chloride
dihydrate, low gelling agarose and gelatin from porcine skin, soy bean
oil were purchased from Sigma-Aldrich (USA). Calcein AM, Propidium
Iodide (PI), Phosphate buﬀer saline without calcium and magnesium
(PBS), Dulbecco’s modiﬁed eagle medium (DMEM) were purchased from
Invitrogen (USA). Metallic meshes of diﬀerent sizes ( 125 -200µm) (for
separation of powders) were purchased by Retsch (Germany). The nee-
dle of the electro hydro dynamic apparatus was a gauge 22S ( Outer
Diameter: 0.718 mm, Inner Diameter: 0.168 mm) was made of type 304
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stainless steal and was purchased from Hamilton (Bonaduz/Switzerland).
Neuroblastoma B50 cells line were purchased from the Istituto Proﬁlat-
tico Sperimentale, Brescia, Italy.
3.4.3. Methods
3.4.3.1. Preparation and sterilization of alginate, gelatin and oil.
Alginate powder was dissolved in PBS for 8 hours at room temperature
under mild stirring to obtain a 2 % alginate solution (2g/100ml). Under
a biological sterile hood the solution was loaded in a syringe and capped
with a 0.22 µm Luer lock ﬁlter, at the other end of the ﬁlter a vial
was attached and sealed with paraﬁlm. The syringe was placed on an
electrical pump set at 0.01 ml/min and ﬁltered overnight. The sterile
solution obtained in the vial was immediately used after ﬁltration. The
gelatin powder was dissolved under mild stirring in PBS for 3 hours at
45°C to obtain a gelatin solution (10g/100ml=10% , 20g=100ml=20%).
The gelatin solution was ﬁltered in a oven set at 45°C.
3.4.3.2. Preparation of gelatin containing cells
The cell culture was performed using standard protocols, exactly as de-
scribed in a previous section of this chapter (sec. 3.2.3.2) using gelatin
instead of alginate. In brief starting from a frosted vial of B50 cells a
standard protocol was followed to obtain a culture of cells at conﬂuence
inside a 175 cm2ﬂask. Cells were detached, counted and the right amount
of warm gelatin solution was added to get 5 millions cell per ml of gelatin.
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3.4.3.3. Encapsulation with metallic sieve as mold
The solution was poured on the sieve and carefully spread on the metallic
net. The metallic sieve was left in a vertical position for ﬁve minutes to
remove all the solution that didn’t ﬁlled the voids of the sieve. Afterward
the entire sieve was put in calcium chloride for crosslinking. With gelatin
the protocol was similar but instead it was performed in a oven at 39°C
on a preheated sieve. The sieve ﬁlled with gelatin solution was moved at
room temperature to crosslink. A ﬂux of nitrogen was used to remove
the capsules from the metallic sieve in order to remove the hydrogel
capsules. Underneath the sieve a water bath was placed to collect the
capsules ejected from the sieve.
3.4.3.4. Gelatin in Oil Emulsion
A 50/50 blend of Span80 and Tween80 were used to stabilize the gelatin in
the emulsion, 0,5 ml of the blend was added to 12,5 ml of sterile soybean
oil, stirred and warmed up to 39 °C. About 2 ml of gelatin containing
cells were added to the emulsion under stirring at room temperature,
after 3 minutes the solution was moved inside a fridge for 5 minutes. A
50 ml vial was ﬁlled with the solution containing the beads and water
was added to ﬁll it completely. The vial was stirred for 10 minutes at
1000 rpm. The supernatant was removed leaving the gelatin beads in the
bottom. The procedure was repeated two times to remove most of the
oil.
3.4.3.5. EHD co-encapsulation and release
The alginate solution was added to the capsules produced with the water
in oil emulsion, to obtain a 25% vol/vol of capsules in alginate. The
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same procedure preciously described (sec. 3.2.3.4) was performed. In brief
the alginate solution containing gelatin capsules was forced through the
positively charged needle thanks to a pump set to a ﬁxed ﬂux. The
beads ejected from the needle were collected in a calcium chloride bath
and washed several times in PBS at room temperature before moving
them inside a ﬂask to an incubator.
3.4.3.6. Confocal Microscopy
The same method for alginate capsules without gelatin described in
sec. 3.2.3.7 was performed, in brief it consists of two passages aimed
at staining the cells with two diﬀerent molecules. First an incubation
in Calcein AM is performed followed by an incubation with Propidium
Iodide.
3.4.3.7. Cell release
Cell were release from the beads following the method previously de-
scribed (sec. 3.2.3.4). In brief beads were stirred and the nutrient solu-
tion was removed, some washes with PBS were performed to remove any
residual divalent cation that could make the dissolution slower. Beads
were placed in an incubator with PBS at 37 °C. Finally cells could be
collected after stirring.
3.4.4. Results and discussion
3.4.4.1. Encapsulation with metallic sieve as mold
The initial tests with alginate gave decent results, the capsules were
formed and successfully ejected from the metallic sieve keeping their
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shape. The solution had to be spread on the metallic sieve very carefully
so that only the voids were ﬁlled to favor the following detachment. The
ﬂux of gas actually teared the capsules from the metallic sieve as shown
in Fig. 3.29 where it was possible to see the unclean cuts on the edges of
the capsules.
Figure 3.29.: Metallic sieve on the left still containing some capsules,
on the right the capsule after the ejection from the sieve
This technique applied to gelatin didn’t led to similar results, it was much
more diﬃcult to spread the gelatin solutions (10%, 20%) on the sieve. A
shown in Fig. 3.30 rather than ﬁlling only the voids a thin coating was
formed leading to a much more diﬃcult detachment of the capsule.
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Figure 3.30.: Sieves and solution spreading. On the left metallic sieves
only, in the middle sieves with alginate after partial ejection of beads,
on the right sieve with gelatin, the gelatin didn’t ﬁll only the pores as
alginate.
As seen from Fig. 3.31 some capsules could be ejected but in most cases
there was a complete detachment of the coating leading to the detach-
ment of cluster of capsules. With high ﬂuxes of gas the gelatin capsules
were destroyed rather than ejected. Diﬀerent concentration of solution
were tested as diﬀerent intensity of gas ﬂux but a good balance that could
lead to the ejection of single capsules without destroying them could not
be found.
Figure 3.31.: Gelatin capsules formed by a metallic sieve, on the left
a gelatin capsules on the right the detachment of the gelatin coating
formed on the sieve
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3.4.4.2. Gelatin in oil emulsion
An aliquot of the solution containing the gelatin beads was taken from
the middle of a vial with a pipette after the washing procedure and a
drop was placed on a microscope slide. A picture was taken and as it’s
shown from Fig. 3.32 B oil is still present on the top of the drop regardless
of the washing performed after the preparation of the capsules. As show
in Fig. 3.32 A the diameter of the capsules ranged from 10 to 70 µm
Figure 3.32.: Gelatin capsules without cells: capsules collected from
the bottom of the vial (left) and oil present on the top (right)
This technique allowed the fabrication of smaller capsules if compared
to the EHD process. In fact with the EHD process set up in the jetting
mode it was possible to obtain capsules with a mean diameter between
150 and 200 µm but with a much lower dispersion of results.
The addition of cells led to capsules with a diameter that was even more
dispersed but given the goal of these experiments the dispersion of the
diameters observed was not considered an issue. The presence of the
capsules with a diameter higher than 100 µm didn’t allow to use a gauge
33 needle ( I.D. 108 µm) as in the previous experiments. For this reason
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a gauge 22S (I.D. 168 µm) needle was chosen for the coencapsulation in
alginate with the EHD process.
Figure 3.33.: Gelatin capsules containing cells, bar is 250 µm
It should be noted that there are many factor related to temperature con-
trol that should be taken into consideration. After placing the gelatin
solution in oil some time is necessary for the gelatin to become an hydro-
gel. The sol-gel transition also depends from the materials gelatin is in
contact with, for example higher temperature are needed if the gelatin
is placed in a metallic sieve, like the one we used in our previous experi-
ment, compared to a polypropylene plate. Typically a reasonable amount
of time is needed to allow the sol-gel transition but in the presence of cells
there are time issues that must be respected since cells are not in their
physiological environment. So the solution was placed in a refrigerator
to increase the cooling rate and favor the sol-gel transition but excessive
low temperature could aﬀect cell behavior. For these reason the duration
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of the solution inside the refrigerator was hard to establish and was set
to 5 minutes after a trail and error approach.
3.4.4.3. Gelatin and alginate with EHD encapsulation
The EHD process using an alginate solution containing gelatin beads
was inclined to clogging, the needle was changed and cleaned very of-
ten. However gelatin laden beads could be manufactured, as shown in
Fig. 3.34.
Figure 3.34.: Gelatin capsules inside an alginate bead
Since the needle system was clogging often a constant supervision was
necessary and a long time was needed for the encapsulation process due to
the many interruption of the process . Needles with bigger inner diameter
exists but with those needles a much higher voltage is needed to reach
the jetting condition obtaining beads bigger than 1 mm. It should be
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noted that the process took place at room temperature to avoid the sol-
get transition of the entrapped gelatin. It took more than one hour from
the end of the cell culture to the end of the encapsulation when the beads
where placed back in the incubator.
3.4.4.4. Confocal
The pictures taken with the confocal microscope show portion of the
beads with a high density of living cells while other parts have some
green spots corresponding to living cells.
Figure 3.35.: EHD encapsulation confocal images, on the left laser only
and on the right laser plus light to outline the borders of the beads.
In other occasions this subdivision could not be observed and living cells
were present in extend portions of the picture. We believe that the shear
stresses of the ﬂow of solution and the ones present at the tip of the
needle of the EHD encapsulation system destroyed part of the gelatin
beads, partially spreading the cells inside the alginate.
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3.4.4.5. Cell release
Cells didn’t reattach after being release from the beads. This was un-
expected since the confocal observation show very few dead cells in the
beads.
3.4.5. Conclusion
Gelatin is an interesting material given its thermo responsiveness at tem-
peratures close to physiological ones but its use in a coencapsulation sys-
tem leads to problems diﬃcult to overcome. Starting from the encapsu-
lation of cells inside the gelatin there were aspects related to temperature
control diﬃcult to overcome because the process must be quick to avoid
thermal stress on cells. In order to have a stable gelatin in oil solution
surfactants were added and as consequence the removal of oil with water
based solution was diﬃcult, more washes were needed that makes the
encapsulation process even longer. Furthermore the use of surfactants
like Tween and Span in close contact with living cells it’s debated for
the their potential toxicity. Overall the process was abandoned given its
shortcomings, in particular because of the clogging of the machine. In
order to avoid it a bigger needle should be used that leads to bigger beads
which ﬁnd limited application, especially if this encapsulation system is
used for a printing apparatus where small spot sizes are needed.
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4. Electro hydro dynamic
printing
4.1. Introduction
A bioprinter is made of a positioning and a deposition system, a bioink
that feeds the deposition system which can contain cells, a biopaper that
is the substrate where the cells and/or the scaﬀold lies after being printed.
For example Xu et al. [102] reported the possibility to adapt commercial
ink jet printers with a thermal head to print viable cells while Cui and
Boland [23] with a similar printer were able to print human microvascu-
lar endothelial using a bioink made of cells and ﬁbrin. Also laser printer
have been studied, for example Barron et al. [7] used a forward transfer
technique in which a laser transfers cells from a biological medium to a
receiving substrate while Ringeisen et al. [76] printed pluripotent em-
bryonal carcinoma cells with minimal single-strand DNA damage. These
system have been proved valid in speciﬁc situations but a system able to
print samples in 3D with high throughput good spot resolution and high
load volume at the same time is still missing [77].
A valid deposition system is generally a system that allows a controlled
ejection of undamaged cells that travel for a relative short distance be-
fore reaching the target deposition substrate. The electro hydro dynamic
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jetting (EHDJ) system potentially fulﬁll this requirement. Moreover is
a high throughput system that needs relatively low cost equipment com-
monly found in research laboratories is able to create micron size beads
and the feeding solution is supplied through a syringe driven by a pro-
grammable pump giving a wide range of loading options [11].
In the EHDJ a solution (bioink) is fed throw a positively charged metallic
needle, the solution reacts to the presence of the charge generating re-
pulsive forces and creating a jet. The EHDJ is a jetting system governed
by process parameters that can be easily changed, some of them dynam-
ically without stopping the deposition system (voltage, ﬂux of solution,
distance from target) possibly leading to diﬀerent geometrical features of
the ejected drops [60].
EHDJ has been investigated with good results to print scaﬀolds for bi-
ological applications, for example Kim et al. [47] successfully printed a
2D layer of collagen on an agarose coated glass while Gupta et al. [38]
were able to print biodegradable and non biodegradable nanocomposite
scaﬀolds into predesigned structures with a thickness limited to ﬁve lay-
ers of material. There is also a raising interest in the EHDJ process to
electrospray viable undamaged mammalian cells, for example Mongkold-
humrongkul et al. [61] proved that the EHDJ process have no signiﬁcant
impact on gene expression and as a consequence on general cell func-
tion while Clarke et al. [20] demonstrated the ability to electrospray
multicellular zebra ﬁsh embryos without harmful eﬀects.
EHDJ is a process that can also be exploited for encapsulation of living
cells using an alginate solution [100], commonly used for encapsulation of
living cells [64] since it’s permissive to nutrients diﬀusion and undergoes
a sol-gel transition under conditions compatible with cell survival. Mul-
tivalent cations (for example Calcium or Barium ions [72, 29]) bind the
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guluronic blocks of the alginate chains, creating ionic interchain bridges
which cause the geliﬁcation of aqueous alginate solutions [80, 53]. Al-
ginate can also be chemically modiﬁed to tune its degradation kinetics
[106] or can be chemically treated to dissolve and to release the cells
entrapped [87].
Combining together EHDJ, a computer aided positioning system, an al-
ginate solution containing cells and a proper deposition substrate we
believe it’s possible to join the two phases of scaﬀold fabrication and cell
seeding by assembling in one single step a scaﬀold permissive to nutrients
diﬀusion already containing living cells.
In this work we proved the possibility to use computer controlled EHDJ
printing techniques to obtain depositions of cell laden hydrogels studying
the main process parameters and evaluating the eﬀect of the process itself
to cell viability. As a substrate we used gelatin , a thermoresponsive
polymer that undergoes a reversible sol-gel transition under 34-36°C and
being liquid at physiological conditions[49] can be easily removed from
the printed sample. Using this hydrogel enriched with calcium ions as
biopaper it was possible to crosslink the alginate bioink upon contact on
the substrate without the need of further processing.
4.2. Materials
Alginic acid sodium salt from brown algae (alginate), calcium chloride di-
hydrate, low gelling agarose and gelatin from porcine skin were purchased
from Sigma-Aldrich (USA). Calcein AM, Propidium Iodide (PI), Phos-
phate buﬀer saline without calcium and magnesium (PBS), Dulbecco’s
modiﬁed eagle medium (DMEM) were purchased from Invitrogen (USA).
The positioning system of the printer is a Janome JR2000N desktop robot
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(Japan), the deposition system is made of a generator (ES30, Gamma
High Voltage Research Inc, USA), a pump (NE-300, New Era Pump Sys-
tems, USA), a polytetraﬂuoroethylene tube and a gauge 33 stainless steel
needle (outer diameter: 0.210 mm, inner diameter:0.108 mm Hamilton,
Bonaduz/Switzerland). Mouse ﬁbroblasts 3T3 cells line were purchased
from the Istituto Proﬁlattico Sperimentale, Brescia, Italy.
Figure 4.1.: EHDJ deposition system
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4.3. Methods
4.3.1. Preparation and sterilization of alginate, agarose
and gelatin
Alginate powder was dissolved in PBS for 8 hours at room temperature
under mild stirring to obtain a 2 % alginate solution (2g/100ml). Under
a biological sterile hood the solution was loaded in a syringe and capped
with a 0.22 µm Luer lock ﬁlter, at the other end of the ﬁlter a vial
was attached and sealed with paraﬁlm. The syringe was placed on an
electrical pump set at 0.01 ml/min and ﬁltered overnight. The sterile
solution obtained in the vial was immediately used after ﬁltration. The
agarose powder was dissolved under mild stirring in PBS for 3 hours
at 60°C to obtain a 2 % agarose solution (2g/100ml). Similarly to the
alginate, the agarose solution was ﬁltered but this time the ﬁltration
process took place in a oven set at 45°C. For the gelatin coating a 400
mM calcium chloride solution was prepared by dissolving the salt in PBS,
gelatin powder was added and dissolved under mild stirring condition at
40°C for 3 hours to obtain a 10% gelatin solution (10g/100ml). The
ﬁltration process of gelatin was the same of agarose with the oven set at
40°C. After ﬁltration the solution in the vial was poured in a 94 mm Petri
dish under a biological hood at room temperature, the Petri coated with
gelatin was left under the hood for 3 hours to allow the sol-gel transition,
20ml of solution were used for each Petri dish.
4.3.2. Preparation of alginate containing cells
The cell culture was performed using standard protocols, in brief about
one million of 3T3 mouse ﬁbroblasts cells were defrosted and seeded in
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a 25cm2 ﬂask using DMEM containing 2mM Glutamine and 10% Fetal
Bovine Serum (Gibco) as culture medium. After 24 h cells were washed
in PBS to remove residues of DMSO left from the freezing solution. At
sub conﬂuence (80%) cells were detached from the ﬂask with 0,05 %
Trypsin/EDTA (Euroclone) and reseeded in a 175 cm2 ﬂask. At conﬂu-
ence cells were detached and moved to a 15 ml vial. Cells inside the vial
were stirred at 1000 rounds/min for 10 minutes and the supernatant was
removed. In order to remove any residue of medium containing cations
that could crosslink the alginate solution, cells on the bottom of the vial
were resuspended in PBS and stirred again. Cells were dispersed by vi-
bration inside the buﬀer and an aliquot of the solution was taken to count
the cells using a Cellometer Auto T4 and Trypan Blue 0,4% (Invitrogen)
as contrast agent. Cells were stirred again, and after removing the su-
pernatant the alginate solution was added to obtain an alginate solution
containing 5 millions cells for milliliter. Medium, PBS, Trypsin/EDTA
and the alginate solution used were prewarmed at 37°C.
4.3.3. Printing
The printer (see Fig. Figure Fig. 4.2 on page 95 A) was carefully cleaned
with ethanol and placed under a biological hood. It consist of a position-
ing and deposition system which are decoupled and can be run indepen-
dently, in this article we will refer to the printer as the whole apparatus.
The positioning system can be programmed by a computer or by a con-
sole connected to the printer with three degrees of freedom. It consists
of a metallic plate moving linearly (x) on the base of the printer and a
plastic holder above it moving in y and z. A metallic plate connected
to the ground of the generator was placed on a polymeric insulator ly-
ing on the printer to avoid conductive contact between the two metallic
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objects. The Petri dish coated with the gelatin hydrogel containing ions
was placed on the plate. The dropping system consist of a needle with a
custom ﬁt that was placed in the plastic holder of the printer above the
plate and connected to a polytetraﬂuoroethylene tube with a Luer lock,
The tip of the needle was connected to the positive cathode of the gener-
ator. The other side of the polytetraﬂuoroethylene tube was connected
to a 3 ml syringe loaded with alginate solution and placed on a pump set
to a ﬁxed ﬂux. A calibration was performed for each Petri dish, in par-
ticular the z axis of the printer was set as zero when the needle touched
the gelatin coating. To perform the experiments the pump was started
and when the solution reached the tip of the needle the generator was
turned on and the printing program was initialized. In order to remove
the samples from the coating the Petri dish was placed in an incubator to
obtain a gel-sol transition of the gelatin, this way the alginate deposition
could be easily removed from the gelatin solution using tweezers.
4.3.4. Agarose mold and alginate dissolution
Some of the alginate depositions containing cells were entrapped in a
agarose mold for post processing. First some agarose was poured to coat
the bottom of the bottom of a 24 wells plate and left at room temperature
to undergo the sol-gel transition. Once the coating was obtained the
alginate deposition was placed on the hydrogel and more liquid agarose
was poured in the wells. The samples were left at room temperature until
the second layer of agarose became an hydrogel. Samples were removed
with tweezers, placed in a 6 well plate containing DMEM and moved in
an incubator.
To dissolve the alginate, ﬁrst the supernatant was removed and the sam-
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ples were washed with PBS at 37°C, a Trypsin/Hepes solution was added
and the samples were moved to an incubator for twenty minutes. Sam-
ples in the agarose mold were cut with a scalpel to give cells a way out
from the hydrogel and observe the reattachment on the tissue culture
plate.
4.3.5. Confocal microscopy
A live/dead assay with Calcein AM and Propidium Iodide was performed
on printed hydrogel samples using standard protocols. In brief the sam-
ples were moved with tweezers to a new plate containing medium with a
10% v/v Calcein-AM solution, then the well plate was placed in a dark
incubator for 30 minutes. At the end of the incubation time the samples
were moved to a new well plate and washed three times before adding
a 2% v/v Propidium iodide solution. The samples were left for 3 min-
utes protected from light at room temperature and washed again. All
solutions used were at 37°C. Observations with the confocal microscope
(Nikon A1, Japan) were performed in wet state, a separate image was
taken for each setup.
4.4. Results
4.4.1. Description of printing process
The printing process can be tuned either to obtain single dot or continu-
ous line deposition. Fig. Fig. 4.2 B shows two diﬀerent kinds of parallel
depositions obtained with one single run of the printer, the ﬁrst is a con-
tinuous deposition while the second is a series of aligned dots parallel
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to the ﬁrst. This sample was obtained by programming the printer to
perform a 100 mm deposition of alginate on a straight line along y then
changing the x coordinate and moving back in a parallel path along y
increasing the speed of the needle and the ﬂux of solution but keeping
the distance from target and applied voltage constant. The ﬁrst deposi-
tion clearly shows separate beads formed by the EHDJ process laying on
the gelatin coating, while the straight line results from the coalescence
of closed packed dots, as evidenced in the optical microscope image in
Fig. 4.2 D where the boundaries between the beads can be recognized.
Figure 4.2.: Deposition of alginate A) the printer B) two diﬀerent kinds
of deposition by changing the speed of the needle C)thickness of the
continuous line deposition D) beads that “fuse” together to create a
continuous line
In the optical microscope image on Fig. 4.2 it’s possible to observe per-
fectly aligned and almost equally spaced dots, by decreasing the speed of
the needle the inter space become lower until the beads collide forming
a continuous deposition.
The beads undergo a fast sol-gel transition upon contact to the gelatin
hydrogel containing calcium cations so that an hydrogel immediately
forms sticking to the coating and maintaining its position. In a EHDJ
process the drops eject from the needle at high speed and this aspect
can be observed on the printed samples. In fact as a result from the
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Figure 4.3.: Beads closer together by decreasing the speed of the needle.
Bar is 500 µm
impact the beads tend to squeeze on the coating losing the spherical
shape . It’s likely that the sol gel transition starts from the initial contact
point between the gelatin and the alginate then, given the speed of the
beads and the beads squeezing on the surface, this contact area becomes
bigger increasing the amount of solution in contact with the cations.
Subsequently the cations diﬀuse in the alginate leading to a complete
sol-gel transition of the whole bead.
Fig. 4.4 shows an horizontal and vertical deposition of alginate crossing
each other. The two depositions joins in the point of contact and the
joint has enough mechanical properties so that in can be lifted from the
liquid gelatin.
The ability of alginate to diﬀuse divalent cations allows the fabrication
of thicker printed samples by a layer by layer deposition. The thicker
the deposition is the more time is needed to obtain a sol-gel transition
of the last deposited layers. For this reasons a pause could be necessary
after each layer in the case the diﬀusion speed is not suﬃcient to fully
gelify the alginate. This is particularly evident for small samples where
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Figure 4.4.: Cross shaped alginate deposition with enough mechanical
properties to be handled. Bar is 500 µm
this pause is necessary to avoid the deposition of alginate solution on top
of a layer of alginate that is still partially liquid. If the sample is big
enough and, as such, the printer takes more time to complete each layer
this pause is not necessary (ex Fig. 4.5).
Given the deposition process used and the experimental setup it’s not
possible to control the start of the drop formation. Once the generator
is turned on a short time is needed to establish a jet of drops, so it’s not
possible to predict when the ﬁrst drop will be ejected from the needle. For
this reason it was convenient to plan a deposition that include a sacriﬁcial
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Figure 4.5.: Square shaped continuous deposition, border 5 cm. On the
right magniﬁcations that show the evolution of the deposition increas-
ing the number of layers.
part that can be easily removed at the end of the printing process. Fig
Fig. 4.6 A shows parts of the procedure to obtain a small multilayered
sample, for example if a cylindrical structure with a diameter of 3 mm
(average diameter) must be printed, it was found convenient to move
the needle slowly in a “standby area” (zone between points 1 and 2) to
allow enough time for the sol-gel transition of the previously deposited
layers, then to rapidly accelerate in a fast approaching zone (between
points 2 and 3) to limit material deposition and facilitate the removal
from the ﬁnal construct. Once in the deposition zone ( circular ring
after point 3) speed is set for optimal deposition. Full 3D fabrication
can be obtained by the overlapping of layers, repeating the procedure
progressively increasing z position of the needle.
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Figure 4.6.: Printing a “small thick sample”, A) initial deposition de-
sign with sacriﬁcal part B) sample with sacriﬁcal part removed C and
D) sample after few layers of deposition.
4.4.2. Process parameters
The EHDJ printing process is inﬂuenced by easy to control parameters
such as: the ﬂux of solution ﬂowing through the needle, the potential
applied, the speed of the needle in the x and y plane and the distance
from target (the length between the tip of the needle and the top of the
gelatin coating underneath it). Since the speed of the needle was found to
have a strong inﬂuence on the characteristics of the printed samples, we
tested all the aforementioned parameters versus speed, ranging from 1 to
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6 mm/s. As a starting set up we printed samples at 14KV, 0.01ml/min
at a distance of 5 mm varying one single parameter for each experiment.
4.4.3. Flux of solution vs speed
Increasing the ﬂux of solution from 0.005 to 0.01 and 0.02ml/min more
deposition were continuous and thicker. At 0.005 ml/min the tendency
was to obtain dotted depositions, partially bridged together at low speeds
while at 0.02 ml/min the tendency was opposite and more continuous
deposition could be obtained with only one dotted printed line at the
highest speed tested (6 mm/s). At 0.01 ml/min the depositions were
continuous at low speeds becoming aligned dots at higher speeds. All
the tested samples didn’t present any deviations from a straight line. For
each set of samples it’s possible to observe an inverse relation between
speed of needle and diameter of the deposition, with smaller deposition
obtained at higher speeds. Deposition are generally thicker at higher
ﬂuxes. For example it’s possible to observe dots showing a diameter of
about 250 at 0.005 ml/min and 6 mm/s speed rising up to almost 500
µm with solution ﬂow set at 0.02 ml/min.
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Figure 4.7.: From left to right depositions at 0.005ml/min, 0.01ml/min,
0.02ml/min. Top row shows the geometrical feature of the depositions
varying the needle speed from 1 to 6 mm/s. Middle row shows deposi-
tions obtained at 1 mm/s while last row shows depositions at 6 mm/s.
Scale bar is 500 µm
4.4.4. Voltage vs speed
The tested voltages ranged between 12 to 20 KV with increments of 2
KV. At 12KV a proper jet of drops could not be established as shown in
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Fig. Fig. 4.8: single beads are deposited by gravitational dripping and
they are closer to each other at lower speed. From 14 KV up the jet of
drops could be established. By further increasing the voltage a certain
degree of disorder appears on the printed samples. At 20KV the voltage
is too high to obtain an ordered deposition, all the lines are misaligned
and irregular.
Figure 4.8.: Geometrical feature at diﬀerent voltages of the depositions
varying the speed of the needle from 1 to 6 mm/s, the magniﬁciations
show the depositions obtained at 6 mm/s. Bar is 500 µm
102
4.4 Results
4.4.5. Distance from target vs speed
The tested distances from target ranged between 4 and 7 mm. At 4 and
5 mm results are quite similar, there are two continuous lines in each
sample at 1 and 2mm/s, all 12 depositions (either continuous or dotted
lines) are uniform and straight. By increasing the distance from target
over 5mm the beads ejected from the needle tend to aggregate in speciﬁc
spots leading to deposition lines with a diameter that changes along the
deposition path. At 7 mm it’s possible to observe deviations from a
straight line. For distances under 4 mm the tip of the needle is too close
to the gelatin target and there are electrical discharges between the two
objects inhibiting the jet formation.
Figure 4.9.: From left to right depositions at a distance of 4, 5, 6, 7
mm showing the geometrical feature of the depositions varying the
needle speed from 1 to 6 mm/s (left ot right). Magniﬁcations show the
depositions obtained at 1 mm/s. Bar is 500 µm
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4.4.6. Printed samples with cells
In order to assess the possibility to use EHDJ printing to deposit alginate
hydrogel scaﬀolds containing living mammalian cells we chose the most
uniform and ordered deposition among the ones obtained in the previous
tests, in particular we observed samples printed at 14KV, 0.01 ml/min, 4
mm/s at a distance of 5mm starting with an alginate solution containing
5x106 cells /ml.Samples observed at the confocal microscope result from
5 layers deposition. We preferred to observe samples made of more than
one layer to asses if this technique is usable for printing 3D living con-
structs. All the observed samples were printed on a single gelatin coated
Petri dish from the same solution of alginate containing cells.
Figure 4.10.: Alginate deposition after 1 day (left) and 7 days of culture
(right)
Samples were cultured for 1 and 7 days before observing them with the
confocal microscope, in both cases they showed to maintain entrapped
cells viable and evenly distributed (Fig. 4.11). It seems that there is no
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substantial diﬀerences between samples at day 1 and sample at 7 days in
terms of number of cells.
Figure 4.11.: Alginate EHDJ deposition after 7 days: on the left picture
at optical microscope, on the right a 3D image obtain with the confocal
microscope
Some samples were molded in agarose and underwent the dissolving pro-
cedure of alginate at day 6. After being cultured for 1 day they were
observed with confocal and optical microscope. As shown in Fig Fig. 4.12
the treatment determines a change in cells distribution inside the sample:
cells rather than being evenly distributed in 3 dimensions tend to form
a two dimensional coating in the agarose. Cells released from the matrix
were able to move outside the cut mold and reattach on the tissue culture
plate.
4.5. Discussion
The ﬂux of solution plays a crucial role. An high ﬂux of solution is nec-
essary to obtain an high throughput but this leads to thicker depositions
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Figure 4.12.: Alginate EHDJ deposition after treatment: on the left
picture at optical microscope, on the right a 3D image obtain with the
confocal microscope
and consequently to a lower resolution bioprinter. On the other side it’s
possible to partially mitigate this phenomenon by increasing the speed of
the needle. The increase of ﬂux and needle speed leads to some complica-
tions in the process: higher ﬂux means higher pressure in the deposition
system which could be harmful to cells considering that they have to ﬂow
through an oriﬁce slightly bigger than 100 µm.
Considering the voltage the best set up is the one that creates a jet of
beads at the minimum voltage which is the condition to obtain the the
most ordered depositions. In fact, increasing the voltage, the depositions
are less uniform and particularly at 20KV it’s possible to observe also
the presence of very small beads. Reasonably the high voltage that gen-
erates the initial jet creates droplets with a high charge to mass ratio
that overcome the Rayleigh limit rising a secondary disintegration. The
secondary disintegration is very diﬃcult to control determining the con-
ditions for a disordered deposition. It should be noted that with our set
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up higher voltages are needed to obtain a jetting conditions compared to
the typical results found in literature concerning cell encapsulation (6 - 7
KV)[57] where the beads are ejected directly in a calcium chloride bath.
We believe that the presence of the gelatin coating between the cathode
and the anode mitigates the eﬀect of the applied voltage. In fact if the
generator is turned on at 14 KV when the needle is far from the gelatin
the jetting condition is initiated and then it stops if the needle is moved
closer to the gelatin to start again if the gelatin is removed.
It’s worth of note that for each distance from the target it was possible to
ﬁnd the best voltage to obtain an ordered deposition. Shorter distances
are generally preferred since the droplets, once ejected, are subject to
perturbations that inﬂuence their trajectory. However if the distance is
too short electric discharge could occur at the needle tip before overcom-
ing the Rayleigh limit which determines the jetting condition. For our
setup the best distance possible were 4 and 5 mm. On this matter it’s
worth of note that most of commercial bioprinters previously presented
need a strict calibration of the z axis in order to cleanly deposit succes-
sive layers of material and a precise z mapping of the sample if it doesn’t
have a planar shape. By having a range of possible suitable distance for
our printer this strict approach is not needed.
We didn’t test other parameters characterizing the process like polymer
concentration, density of cells and diameter of needle since their eﬀect
on the EHDJ process were already characterized (data not shown). In
brief the best concentration of alginate was found to be 2% since higher
concentrations are too viscous while lower concentration are more likely
to create secondary disruption of the beads and as such irregular deposi-
tions. The density of cells in the starting solution has an inﬂuence in the
EHDJ process, for example higher cell densities (10− 20× 106 cells/ml)
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needs a higher voltage to establish a jet of drops. However once the jet
of drops is established there are no substantial diﬀerences on the diame-
ter of the ejected beads. Finally, the diameter of the needle was chosen
because it was the best compromise between viscosity and printer spot
size since higher diameter allow higher ﬂux of solution but increase the
spot size of the printer creating bigger beads.
Spot size (µm) Max print speed (ml/s) Max cell throughput(cells/s)
Our printer 250-1000 0.02 ml/s 1600 (6000*)
Laser Guided Direct Write 30 9x10−8 ml/s 0.04
Modiﬁed Laser Induced Forward Transfer 30-100 102 drops/s 104
Inkjet - Thermal >300 5x105 drops/s 850
Inkjet - Piezo Not reported 1x104 drops/s 2
Syringe Extrusion >300 Continuous Not reported
Loaded volume (ml) Cell viability (%)
Our printer 3* (50*) >95
Laser Guided Direct Write Not reported Not reported
Modiﬁed Laser Induced Forward Transfer 20 x10−3 >95
Inkjet - Thermal 0.3 - 0.5 75 - 90
Inkjet - Piezo 0.3 - 0.5 -
Syringe Extrusion 0.6 >90
Table 4.1.: Feature of the printer system reported (gray background)
compared to other printers found in scientiﬁc literature (white back-
ground). * Tested but not reported[77]
In Tab. 4.1 we reported some features of the printer used in these ex-
periments and compared to other printing system found in scientiﬁc
literature. This table doesn’t consider the ability to print directly 3D
structures that in some cases is missing. As an example in the Modiﬁed
Laser Induced Forward Transfer manually added basement membranes
are needed to obtain a multilayered structure. Our printer has a spot
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size similar to the inkjet and syringe extrusion printers and the maximum
cell throughput is among the highest of the reported printers. Moreover
it has a loaded volume dependent on reservoir used on the pump that
can mount up to 50 ml syringes. This high load volume, not available
in all other systems, allows uninterrupted printing for extended periods
of time. Another aspect not present in all other printers is that the part
of deposition system on top of the biopaper has a small size being con-
stituted of only a needle, a cable and tube. This aspect increase the
versatility of the system, for example more EHDJ heads could be used in
parallel with diﬀerent set ups. Furthermore potentially the system can
be adapted to deposit other materials than alginate given some basic re-
quirements like material compatibility with cells in the sol and gel states
and the compatibility of the sol-gel transition with cell survival.
4.6. Conclusions
The electro hydro dynamic process can be exploited to create a jet of
alginate beads that can be precisely deposited on a target surface, for
this reason it’s potentially a good candidate to be used as the deposi-
tion system of a bioprinter. If the target surface is a hydrogel containing
divalent cations the alginate crosslink upon contact without the need of
further processing. The printing process is compatible with cell survival
and allows the deposition of a three dimensional alginate scaﬀold con-
taining living cells. The deposition system used has a small size and now
that the inﬂuence of the parameters of the process are known we believe
is possible to mount more EHDJ heads calibrated to deposit beads on
the same spot, achieving the possibility to use diﬀerent solutions at the
same time.
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In this research work we faced the challenge to design and realize a printer
for living constructs. The research activity has been focused on the main
critical variables conditioning the process: by one side the development
of optimal methods for cell encapsulation to produce cell laden building
blocks, and by the other the setting up and tuning of a proper method-
ology for the controlled and eﬀective placement of the living blocks. By
combining the two processes of encapsulation and scaﬀold production
and by using a speciﬁc substrate for the printed samples it was possible
to obtain a direct printing of computer designed 3D hydrogel scaﬀolds
containing living mammalian cells.
Initially we manufactured samples with a printer similar to commercially
available bioprinters but with a new approach aimed at obtaining directly
3D structures by a direct injection in an hydrogel. The hydrogel acted as
a sacriﬁcial support and had the functional role to crosslink the construct.
Later we designed a more advanced and novel contactless bioprinter that
exploit a deposition technique typically employed for the encapsulation
of cells, the electro hydro dynamic process. The base building blocks of
this printer are cell laden micrometric beads and scaﬀolds are produced
with a bottom-up approach by assembling the blocks piece by piece to
obtain more complex structures.
The electro hydro dynamic process parameters were carefully charac-
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terized to obtain spherical mono sized beads and as such optimize the
spot size of the printer. Biological tests were performed to assess the
condition of diﬀerent kind of entrapped cells inside the beads and once
released from the hydrogel. The beads showed viable cells in a quies-
cent state which were able to regain their viability after dissolving the
entrapping matrix.
The information obtained were transferred directly to the bioprinter and
the printing parameters were investigated to obtain controlled and or-
dered depositions. 3D structures are obtained by the deposition of more
layers of material that crosslink upon contact on the target substrate
without needing any further postprocessing.
The bioprinter has some features that are not available in other system.
It’s contactless, avoiding the need of a strict calibration and a possible
contamination of the sample by the deposition system. The part of the
deposition system over the sample it’s small sized, being constituted only
of a needle, a tube and a cable without adversely eﬀecting the high
load capacity of feeding solution to allow uninterrupted printing for long
periods of time .
Applying computer aided manufacturing to build functional tissue is a
promising approach, but still far from being fully successful. However
the possibility to place small drops of alginate containing living cells at
predeﬁned positions can be exploited for many application. A potential
and promising application could be building a device for the release of
therapeutic molecules , such as insulin, by carefully designing the po-
sitioning of highly cell loaded alginate beads leaving channels for the
nutrient supplies and removal of waste.
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A. Appendix
A.1. Technical data (from the manufacturers)
A.1.1. Eco-PEN300
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A.1 Technical data (from the manufacturers)
A.1.2. Jenome JR2300N
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A.1.3. nScript Bioassembly tool
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A.1 Technical data (from the manufacturers)
A.1.4. Envisiontec 3D-Bioplotter™
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A.1.5. Syseng Bioscaﬀolder
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A.1 Technical data (from the manufacturers)
A.1.6. Standard formulation (salts)
A.1.6.1. DMEM
Component Concentrate mg/L
CaCl2·2H2O 264.92
Ferric Nitrate (Fe(NO3)3-9H2O) 0.10
Potassium Chloride (KCl) 400.00
MgSO4·7H2O 200.00
Sodium Chloride (NaCl) 6400.00
Sodium Bicarbonate (NaHCO3) 3700.00
Sodium Phosphate (NaH2PO4-H2O) 125.00
A.1.6.2. Phosphate buﬀer saline w/o Ca and Mg
Component Concentrate mg/L
Potassium Chloride (KCl) 200.00
Sodium Chloride (NaCl) 8000.00
Potassium Phosphate Monobasic (KH2PO4) 200.00
Sodium Phosphate Dibasic (Na2HPO4) 2170.00
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